This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Pulmonary heart disease
FG_PULMHEART
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
13122 |
6. Filter based on genotype QC (FinnGen only) |
13122 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Pulmonary heart disease
based on the number of shared cases.
Similar with more cases:
- Pulmonary embolism
- Pulmonary heart disease, diseases of pulmonary circulation
- DVT of lower extremities and pulmonary embolism
- Venous thromboembolism
- Cardiovascular diseases (excluding rheumatic etc)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13122 | 6696 | 6426 |
| Unadjusted period prevalence (%) | 2.55 | 2.28 | 2.83 |
| Median age at first event (years) | 65.69 | 64.67 | 66.76 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 11654
- Matched controls
- 116493
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B01AA03
ATC
warfarin; systemic
5.2
323.0
5590
17582
R06.0
ICD-10 Finland
Dyspnoea
3.6
323.0
4803
19046
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
52.9
323.0
1871
420
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
323.0
3940
20443
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
6.2
323.0
1066
1849
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
1663.6
323.0
2886
23
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
8086.0
323.0
9788
71
B01AB10
ATC
tinzaparin; parenteral
5.3
323.0
1720
3658
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
6.6
323.0
893
1451
B01AB05
ATC
enoxaparin; parenteral
4.0
323.0
5862
23741
B01AF02
ATC
apixaban; oral
3.5
323.0
2087
6795
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
323.0
2305
8456
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
323.0
6242
37507
I26
ICD-10 Finland
Pulmonary embolism
163.8
323.0
1004
67
K93
ICPC
Pulmonary embolism
106.0
323.0
1043
108
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
5.1
323.0
2785
6736
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
15.6
323.0
3938
3680
4151A
ICD-9 Finland
Acute pulmonary heart disease, Pulmonary embolism and infarction
+∞
323.0
442
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
37.8
323.0
525
145
B01AF01
ATC
rivaroxaban; oral
2.9
290.4
2075
8138
N02AA05
ATC
oxycodone; systemic
2.5
269.6
2447
11013
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
264.5
2446
11106
C03CA01
ATC
furosemide; systemic
2.0
258.2
4597
28240
JN4BD
NOMESCO Finland
Extensive body CT
2.7
233.0
1789
7246
A03FA01
ATC
metoclopramide; systemic, rectal
2.2
230.0
2847
14809
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
9.6
229.0
488
529
H02AB02
ATC
dexamethasone; systemic
2.8
226.8
1615
6233
B01AB04
ATC
dalteparin; parenteral
3.9
223.9
1020
2829
GD2SN
NOMESCO Finland
Lung ventilation SPECT
19.5
222.0
344
181
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
216.4
2610
13356
130
Kela drug reimbursment
Malignant tumour
2.9
213.9
1449
5403
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
213.3
2837
15156
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
209.5
2984
16395
GD1UN
NOMESCO Finland
Lung circulation SPECT
20.4
207.0
316
159
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.2
202.9
832
2093
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
191.4
1712
7494
A02BC02
ATC
pantoprazole; systemic
1.8
176.5
7523
59262
H02AB06
ATC
prednisolone; systemic
1.7
176.5
5540
39733
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
7.1
172.8
445
651
45001
ICD-8 Finland
Pulmonary embolism and infarction, Embolia
+∞
172.2
165
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.1
171.7
2358
12596
Z51.5
ICD-10 Finland
Palliative care
2.9
162.2
1058
3813
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.6
159.2
1336
5606
JN4AD
NOMESCO Finland
Body CT examination
2.7
154.1
1163
4585
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
152.8
2288
12583
R50.9
ICD-10 Finland
Fever, unspecified
2.2
149.5
1771
8808
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
144.0
1469
6802
D68.8
ICD-10 Finland
Other specified coagulation defects
10.6
142.1
285
275
A04AA02
ATC
granisetron; systemic, transdermal
3.0
138.3
894
3189
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
5.8
138.2
414
739
N02AX02
ATC
tramadol; systemic, rectal
1.6
137.1
4995
36412
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.6
136.4
658
1893
R02
ICPC
Shortness of breath/dyspnoea
2.2
135.6
1592
7859
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
130.4
1424
6791
K94
ICPC
Phlebitis/thrombophlebitis
6.5
129.4
354
562
J01MA12
ATC
levofloxacin; systemic
1.9
129.2
2386
14071
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
125.4
1413
6826
R03AC02
ATC
salbutamol; inhalant
1.6
124.7
5553
42285
A04AA01
ATC
ondansetron; systemic, rectal
2.7
124.3
901
3448
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
124.3
2114
12086
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
122.2
3423
22974
R4110
NOMESCO Finland
Physiotherapy
1.7
120.5
3066
19986
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
3.6
120.3
587
1702
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.7
118.9
563
1592
ZX120
NOMESCO Finland
Intravenous
2.3
118.3
1244
5811
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.3
114.5
1127
5093
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
113.0
2054
11976
WX892
NOMESCO Finland
Monitored bed care
2.4
111.7
1059
4693
N02BE01
ATC
paracetamol; systemic, rectal
1.7
110.3
9588
85088
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.7
109.6
834
3276
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
109.1
1940
11207
ZXD05
NOMESCO Finland
Urgent procedure
1.6
108.6
3490
24154
JN3AD
NOMESCO Finland
Abdominal CT examination
2.4
106.4
1016
4515
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
104.7
641
2193
L01BC06
ATC
capecitabine; oral
3.3
103.9
555
1724
AA1AD
NOMESCO Finland
CT of head and brain
1.7
103.1
2902
19314
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
12.5
102.3
188
152
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
101.5
3804
27283
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
100.8
2934
19688
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.4
99.5
524
1610
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
99.5
763
3007
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
6.1
99.4
283
474
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
12.0
97.5
183
155
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
97.4
3402
23910
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
97.3
3115
21407
R03BB04
ATC
tiotropium bromide; inhalant
2.0
96.6
1359
7166
J96.1
ICD-10 Finland
Chronic respiratory failure
4.0
94.3
403
1042
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
93.5
1222
6245
N03AX16
ATC
pregabalin; oral
1.7
92.8
2594
17144
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
4.3
92.8
367
884
M79.6
ICD-10 Finland
Pain in limb
1.5
90.6
3723
27111
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
5.4
90.3
283
533
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.7
89.2
676
2641
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
3.9
89.1
382
991
J01MA14
ATC
moxifloxacin; systemic
2.1
88.9
1097
5467
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
86.5
1032
5067
E66.01
ICD-10 Finland
Obesity due to excess calories
2.4
86.2
786
3397
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.4
85.7
439
1319
WZC30
NOMESCO Finland
Teaching
1.9
84.2
1476
8409
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.5
82.1
668
2717
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
81.6
1966
12392
J01DB01
ATC
cefalexin; oral
1.5
78.4
8631
76373
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
4.3
78.3
302
710
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
77.4
1578
9437
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
76.4
3517
26031
A46
ICD-10 Finland
Erysipelas
1.7
76.4
1672
10220
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
75.1
1612
9787
JN4CD
NOMESCO Finland
Very extensive body CT
2.7
74.8
557
2150
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
19.3
74.7
115
60
R60.0
ICD-10 Finland
Localized oedema
1.8
74.7
1320
7523
J01MA02
ATC
ciprofloxacin; systemic
1.5
73.2
4298
33387
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
70.5
1629
10096
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.0
69.6
424
1440
Z3226
NOMESCO Finland
Physiotherapist
1.6
69.3
2004
13219
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
68.7
4665
37133
I80.20
ICD-10 Finland
Phlebitis and thrombophlebitis in the iliac vein
9.2
67.3
144
158
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
66.9
3233
24021
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
66.5
3681
28109
C07AB07
ATC
bisoprolol; oral
1.4
66.2
5473
45059
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
66.1
3860
29778
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
65.9
511
2019
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.6
65.8
500
1953
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
65.6
1136
6409
A28
ICPC
Limited function/disability NOS
1.6
65.4
1876
12328
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
65.3
4859
39211
SPAT1254
SPAT
Administration of medicine
1.7
65.1
1694
10841
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.4
64.9
609
2664
UJF32
NOMESCO Finland
Coloscopy
1.5
63.6
2829
20607
PH7FT
NOMESCO Finland
Inmplantation of filter to inferior vena cava with radiological guidance
72.5
63.1
72
10
Z3231
NOMESCO Finland
Registered nurse
1.5
62.7
2903
21319
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.7
61.6
1288
7724
C03DA01
ATC
spironolactone; oral
1.7
60.8
1321
8010
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
60.8
1548
9828
J01FF01
ATC
clindamycin; systemic
1.5
60.7
2715
19770
E66.8
ICD-10 Finland
Other obesity
2.5
60.6
501
2050
N05CF01
ATC
zopiclone; oral
1.4
60.5
3623
27960
N05BA04
ATC
oxazepam; oral
1.5
59.8
2569
18535
C02KX05
ATC
riociguat; oral
+∞
59.4
57
*
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
59.4
1519
9654
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
59.2
2052
14096
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
58.9
592
2673
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
58.2
3294
25104
ZXE00
NOMESCO Finland
One hour or less
1.4
57.9
4016
31777
TGC00
NOMESCO Finland
Bronchial lavation
3.0
57.5
352
1202
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
57.4
654
3131
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.7
57.1
262
721
G47.3
ICD-10 Finland
Sleep apnoea
1.5
56.8
2021
13952
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.8
56.7
389
1427
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
4.7
56.7
200
431
M04AA01
ATC
allopurinol; systemic
1.6
56.4
1551
10042
R53
ICD-10 Finland
Malaise and fatigue
1.5
56.2
2187
15404
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.0
56.2
779
4043
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.9
56.2
363
1283
I50.0
ICD-10 Finland
Congestive heart failure
1.8
56.0
1014
5794
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
55.8
1105
6502
I80.2
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
22.6
55.6
81
36
A06AD11
ATC
lactulose; oral
1.6
55.4
1797
12129
WW500
NOMESCO Finland
Blood transfusion
2.4
55.3
498
2131
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
54.7
1613
10622
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
54.2
1868
12780
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.1
54.1
669
3314
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
7.7
54.0
129
170
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.9
54.0
836
4523
TKC20
NOMESCO Finland
Catheterisation of bladder
1.9
53.3
866
4767
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
53.0
1027
5994
N06AX11
ATC
mirtazapine; oral
1.4
53.0
3149
24128
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
53.0
640
3138
Z2446
NOMESCO Finland
Social worker
2.1
52.8
675
3390
XG410
NOMESCO Finland
Flow-volume spirometry
2.4
52.5
485
2102
WX882
NOMESCO Finland
High dependency care
2.8
52.3
355
1295
128
Kela drug reimbursment
Cancers of female genital organs
3.7
51.5
234
640
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.1
50.9
586
2812
SPAT1263
SPAT
Sampling
1.4
50.8
4272
34705
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
50.8
1543
10227
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
50.4
740
3923
L28
ICPC
Limited function/disability (L)
1.5
50.2
1788
12307
L03AA02
ATC
filgrastim; parenteral
2.8
49.9
331
1191
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.7
49.5
1035
6184
N05AH04
ATC
quetiapine; oral
1.6
49.4
1469
9676
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
49.3
577
2790
A02BC01
ATC
omeprazole; systemic
1.4
49.3
2970
22752
A06AH03
ATC
naloxegol; oral
4.5
48.5
177
396
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
47.9
555
2673
WX402
NOMESCO Finland
General anaesthesia
1.6
47.6
1472
9784
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
47.2
452
1993
N06AB04
ATC
citalopram; systemic
1.5
47.1
2141
15514
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
2.3
47.0
475
2149
XG466
NOMESCO Finland
Sleep oxymetry
2.5
46.9
388
1586
SPAT1255
SPAT
Intravenous administration of medicine
1.9
46.9
734
3981
I87.0
ICD-10 Finland
Postthrombotic syndrome
11.7
46.9
88
76
A04AA55
ATC
palonosetron, combinations; systemic
2.8
46.8
312
1125
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
46.7
493
2275
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
46.6
628
3218
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
4.9
46.6
157
323
J94.8
ICD-10 Finland
Other specified pleural conditions
3.3
46.6
244
747
L03AA13
ATC
pegfilgrastim; parenteral
2.4
46.6
408
1720
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
3.0
46.5
275
918
R04.2
ICD-10 Finland
Haemoptysis
2.4
46.3
429
1862
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
46.1
490
2271
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.7
45.9
208
568
WX872
NOMESCO Finland
Intensive care
2.1
45.7
573
2850
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
45.1
675
3601
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
44.5
468
2158
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
44.4
1682
11707
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.7
44.3
201
550
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
44.0
988
6021
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.8
43.7
286
1021
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
43.6
753
4224
WX722
NOMESCO Finland
PEEP
2.1
43.4
527
2590
Z2221
NOMESCO Finland
Medical doctor
1.4
43.1
2698
20714
N06AX16
ATC
venlafaxine; oral
1.6
43.1
1133
7209
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
42.9
685
3739
H02AB07
ATC
prednisone; oral
1.5
42.8
1512
10350
FBB20
NOMESCO Finland
Thrombendarterectomy of pulmonary artery in chronic obstruction
+∞
42.7
41
*
I27.0
ICD-10 Finland
Primary pulmonary hypertension
11.2
42.3
81
73
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.8
41.4
723
4068
J46
ICD-10 Finland
Status asthmaticus
2.6
41.4
320
1263
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.7
41.2
1003
6249
45100
ICD-8 Finland
Phlebitis and thrombophlebitis, Of lower extremities
4.0
41.1
168
420
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
41.1
1709
12121
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.0
40.8
545
2782
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.4
40.7
375
1622
WF004
NOMESCO Finland
Palliative radiotherapy
2.9
40.4
254
885
A02BC05
ATC
esomeprazole; systemic
1.3
40.2
4016
33147
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.5
40.2
329
1339
L04AX01
ATC
azathioprine; systemic
2.2
40.1
427
1980
SPAT1229
SPAT
Assessment of need for aid
1.7
39.9
915
5604
J01FA06
ATC
roxithromycin; oral
1.3
39.8
3996
32994
R4190
NOMESCO Finland
Nutritional therapy
2.6
39.8
311
1235
H02AB09
ATC
hydrocortisone; systemic
2.9
39.8
247
852
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
39.6
523
2659
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.3
39.4
150
351
R11
ICD-10 Finland
Nausea and vomiting
1.7
39.2
805
4771
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.9
39.2
249
872
E66.00
ICD-10 Finland
Metabolic syndrome
2.0
39.1
510
2578
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
39.0
1150
7531
R03DC03
ATC
montelukast; oral
1.5
38.9
1371
9368
J96.0
ICD-10 Finland
Acute respiratory failure
3.4
38.8
196
586
N03AX12
ATC
gabapentin; oral
1.5
38.5
1476
10276
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.5
38.3
304
1218
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.2
38.1
415
1943
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.4
38.1
325
1352
M10.9
ICD-10 Finland
Gout, unspecified
1.8
38.0
702
4022
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
37.7
1693
12174
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.9
37.6
553
2929
N05BA01
ATC
diazepam; systemic, rectal
1.5
37.4
1363
9378
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
4.2
37.2
144
343
SPAT1262
SPAT
Handing over of treatment supplies
1.4
37.2
1871
13754
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
37.1
2020
15066
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
37.1
6425
56935
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
37.0
1165
7747
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.0
36.9
474
2383
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
36.7
610
3376
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
36.6
460
2292
D70.82
ICD-10 Finland
Drug-induced neutropenia
3.2
36.5
198
624
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.0
36.5
218
735
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.2
36.5
381
1751
WX002
NOMESCO Finland
Sedation and analgesia
1.4
36.4
1975
14718
JAH00
NOMESCO Finland
Laparotomy
2.4
36.3
314
1316
R03BA02
ATC
budesonide; inhalant
1.5
36.2
1628
11701
K99
ICPC
Cardiovascular disease other
2.3
36.1
344
1515
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
36.0
1878
13890
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.1
35.9
407
1941
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.2
35.6
195
619
E66.9
ICD-10 Finland
Obesity, unspecified
2.4
35.5
317
1350
R03BA05
ATC
fluticasone; inhalant
1.4
35.3
1659
12022
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
34.9
347
1557
R03AK08
ATC
formoterol and beclometasone; inhalant
2.2
34.6
359
1647
A04AD12
ATC
aprepitant; systemic
2.9
34.6
218
762
L04AA06
ATC
mycophenolic acid; systemic
3.2
34.5
188
595
N05AA02
ATC
levomepromazine; systemic
2.1
34.5
424
2093
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
34.3
680
3983
M05BX04
ATC
denosumab; parenteral
1.9
34.2
551
3015
R18
ICD-10 Finland
Ascites
2.8
34.2
227
821
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
34.1
615
3496
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.1
34.0
398
1923
HA1AA
NOMESCO Finland
X-ray mammography
1.7
33.9
680
3998
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.0
33.9
480
2506
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.7
33.9
151
409
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.8
33.7
662
3866
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
33.6
1442
10258
FB1ST
NOMESCO Finland
Catheter-based therapy of pulmonary embolism
+∞
33.3
32
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
33.3
480
2523
J45.8
ICD-10 Finland
Mixed asthma
2.3
33.3
323
1437
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.7
33.0
238
902
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
32.7
547
3031
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.2
32.6
179
570
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.1
32.6
366
1738
N05AH03
ATC
olanzapine; systemic
1.9
32.6
480
2543
R06.2
ICD-10 Finland
Wheezing
2.0
32.5
408
2032
N30.0
ICD-10 Finland
Acute cystitis
1.5
32.5
1329
9355
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
32.4
968
6348
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.2
32.1
349
1636
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.3
32.0
168
518
S97
ICPC
Chronic ulcer skin
1.8
32.0
590
3378
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.7
31.9
680
4069
GD1CN
NOMESCO Finland
Lung circulation isotope imaging
28.7
31.9
43
15
N06AA09
ATC
amitriptyline; systemic
1.6
31.6
978
6466
UKC02
NOMESCO Finland
Cystoscopy
1.4
31.6
1722
12809
J01DA01
ATC
[U] cefalexin; systemic
1.3
31.4
6326
56541
45000
ICD-8 Finland
NA
+∞
31.2
30
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.0
31.2
129
328
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.4
31.2
265
1102
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.5
31.1
259
1068
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
31.0
3824
32164
PH7ZT
NOMESCO Finland
Intravenous removal of filter to inferior vena cava
60.1
31.0
36
6
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
31.0
765
4773
K78
ICPC
Atrial fibrillation/flutter
1.6
31.0
892
5792
R55
ICD-10 Finland
Syncope and collapse
1.5
30.9
1149
7919
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
30.8
497
2718
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
30.7
345
1640
B01AX05
ATC
fondaparinux; parenteral
3.6
30.6
141
393
H02AB04
ATC
methylprednisolone; systemic
1.4
30.6
1393
10012
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
2.5
30.4
244
985
R07.3
ICD-10 Finland
Other chest pain
1.6
30.3
914
6003
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
30.1
712
4389
GD1FN
NOMESCO Finland
Lung ventilation isotope imaging
32.6
29.9
39
12
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.1
29.8
339
1623
L17
ICPC
Foot/toe symptom/complaint
1.3
29.6
2310
18205
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.3
29.6
285
1264
A04
ICPC
Weakness/tiredness general
1.5
29.4
1218
8589
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.6
29.3
213
814
N05CD07
ATC
temazepam; oral
1.4
29.2
1401
10167
M54.5
ICD-10 Finland
Low back pain
1.3
29.2
2872
23403
WX110
NOMESCO Finland
Local anesthesy
1.2
29.2
6341
56939
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
29.2
3303
27427
N03AX09
ATC
lamotrigine; oral
2.1
29.1
344
1673
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
3.5
29.1
141
410
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
28.9
2461
19639
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.1
28.6
164
538
FB1BC
NOMESCO Finland
Extensive angiography of arteria pulmonalis
19.6
28.6
43
22
N06AB10
ATC
escitalopram; oral
1.4
28.5
1551
11511
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
28.4
567
3328
SPAT1240
SPAT
Therapeutic discussion
1.6
28.3
741
4695
WX730
NOMESCO Finland
Conventional respirator
2.7
28.2
193
711
R03DA04
ATC
theophylline; systemic, rectal
1.7
28.1
635
3865
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.1
28.0
331
1610
C02KX04
ATC
macitentan; oral
24.4
27.8
39
16
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
27.8
735
4668
Z86.7
ICD-10 Finland
Personal history of diseases of the circulatory system
22.3
27.7
40
18
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
27.7
602
3625
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.4
27.6
136
401
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.8
27.3
452
2494
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.6
27.3
209
824
D68.9
ICD-10 Finland
Coagulation defect, unspecified
6.3
27.3
73
116
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.2
27.2
276
1255
E0000UV
ATC
NA
1.3
27.2
3557
30020
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.7
27.1
610
3707
SPAT1301
SPAT
No procedures
1.3
26.9
3123
25956
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.9
26.8
114
298
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
26.8
227
943
J01CA04
ATC
amoxicillin; systemic
1.2
26.7
7879
72857
JAL30
NOMESCO Finland
Omentectomy
3.4
26.7
134
402
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
26.7
947
6457
R42
ICD-10 Finland
Dizziness and giddiness
1.3
26.6
2190
17362
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
26.6
1614
12196
XW000
NOMESCO Finland
Bone marrow biopsy
1.9
26.6
407
2188
S18
ICPC
Laceration/cut
1.3
26.5
4064
34924
P01AB01
ATC
metronidazole; oral, rectal
1.3
26.3
3545
29987
R52.9
ICD-10 Finland
Pain, unspecified
1.6
26.3
740
4773
R03AC03
ATC
terbutaline; inhalant
1.4
26.3
1231
8881
J45
ICD-10 Finland
Asthma
1.5
26.2
816
5396
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.8
26.2
444
2473
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.1
26.1
288
1360
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.8
26.0
173
629
WW200
NOMESCO Finland
Immunization
2.2
25.7
257
1161
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
10.0
25.6
51
51
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
10.0
25.6
51
51
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
3.5
25.6
122
352
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.4
25.5
228
974
RS221
NOMESCO Finland
NA
2.9
25.5
155
532
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
25.3
538
3217
C08CA01
ATC
amlodipine; oral
1.2
25.3
3758
32126
N05AX12
ATC
aripiprazole; systemic
2.3
25.3
241
1065
A07AA02
ATC
nystatin; oral
1.6
25.3
634
3971
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.8
25.2
162
574
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
25.2
3526
29920
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.0
25.2
146
486
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.8
25.1
437
2455
B01AF03
ATC
edoxaban; oral
2.5
25.1
197
788
J01AA02
ATC
doxycycline; systemic
1.2
25.0
8043
74744
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
25.0
347
1798
45003
ICD-8 Finland
Pulmonary embolism and infarction, Thrombosis
+∞
25.0
24
*
T82
ICPC
Obesity
2.1
25.0
282
1344
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
24.9
690
4433
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
24.9
2261
18156
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.3
24.8
244
1095
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.0
24.8
342
1771
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
24.6
239
1064
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.6
24.6
648
4109
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
24.6
1570
11955
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.7
24.6
176
669
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.7
24.5
538
3248
R52.0
ICD-10 Finland
Acute pain
2.2
24.4
264
1239
W19
ICD-10 Finland
Unspecified fall
1.5
24.3
880
6018
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
24.2
533
3217
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
24.2
1794
13985
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.7
24.1
166
618
45099
ICD-8 Finland
NA
+∞
24.0
23
*
ZX108
NOMESCO Finland
Inhalation
4.0
24.0
97
244
X58
ICD-10 Finland
Exposure to other specified factors
1.4
23.8
1092
7836
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.1
23.8
281
1366
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
3.1
23.8
130
416
E66
ICD-10 Finland
Obesity
2.0
23.8
319
1636
A07AA09
ATC
vancomycin; oral
2.9
23.7
150
529
FB1AC
NOMESCO Finland
Angiography of arteria pulmonalis
86.9
23.6
26
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
2.8
23.6
155
560
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.2
23.6
248
1148
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
23.6
3661
31386
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.5
23.4
190
774
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.3
23.3
222
980
K92.1
ICD-10 Finland
Melaena
1.7
23.3
539
3303
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.7
23.3
495
2961
B01AE07
ATC
dabigatran etexilate; oral
1.8
23.3
417
2367
Z71.8
ICD-10 Finland
Other specified counselling
1.3
23.1
1927
15264
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
23.1
810
5499
R04.0
ICD-10 Finland
Epistaxis
1.5
23.1
712
4694
I80
ICD-10 Finland
Phlebitis and thrombophlebitis
3.1
23.1
128
414
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
22.7
491
2954
ZY010
NOMESCO Finland
Hospital outpatient
1.9
22.6
330
1747
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.1
22.4
252
1202
R51.80
ICD-10 Finland
Headache
1.4
22.4
1122
8184
R03AC13
ATC
formoterol; inhalant
1.7
22.3
470
2806
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.6
22.3
527
3250
L14
ICPC
Leg/thigh symptom/complaint
1.6
22.3
669
4384
TK800
NOMESCO Finland
Hemodialysis
2.3
22.2
215
958
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.4
22.2
186
772
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
2.8
22.2
142
506
127
Kela drug reimbursment
Transplant complication
2.8
22.1
144
517
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
22.1
1063
7697
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
22.1
699
4639
GD1CQ
NOMESCO Finland
Lung circulation SPECT with low dose CT
21.4
22.1
32
15
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
22.0
605
3880
G04BE03
ATC
sildenafil; oral
2.7
22.0
156
589
L01BC59
ATC
trifluridine, combinations; systemic
8.7
21.9
47
54
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
21.9
860
5981
N03AE01
ATC
clonazepam; systemic
1.6
21.8
526
3261
RT172
NOMESCO Finland
NA
11.1
21.8
41
37
PH7AC
NOMESCO Finland
Lumbal cavography with X-ray
38.7
21.7
27
7
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
21.5
1739
13704
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
3.0
21.5
124
412
N06AX12
ATC
bupropion; oral
1.8
21.5
371
2080
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
2.9
21.5
135
474
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.4
21.4
106
316
WF003
NOMESCO Finland
Adjuvant radiotherapy
1.9
21.3
320
1712
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.2
21.3
224
1037
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
21.2
2024
16320
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.0
21.2
122
405
XF622
NOMESCO Finland
Measurement of minute volume of heart
6.3
21.1
56
89
J01EA01
ATC
trimethoprim; systemic
1.3
21.0
2420
19978
SPAT1260
SPAT
Consultation of another employee
1.3
21.0
1635
12809
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
20.9
424
2498
I50.1
ICD-10 Finland
Left ventricular failure
1.6
20.9
523
3272
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
20.8
1697
13381
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
20.8
995
7190
N03AX14
ATC
levetiracetam; systemic
2.1
20.8
233
1113
N18.8
ICD-10 Finland
Other chronic renal failure
1.9
20.7
296
1556
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.2
20.6
108
337
R81
ICPC
Pneumonia
1.9
20.6
301
1593
L01CA04
ATC
vinorelbine; systemic
3.4
20.5
102
306
RT360
NOMESCO Finland
NA
13.5
20.4
35
26
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.6
20.4
574
3705
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
8.2
20.3
45
55
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
20.3
959
6915
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
6.4
20.2
53
83
E87.6
ICD-10 Finland
Hypokalaemia
1.9
20.2
294
1553
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
20.2
2272
18690
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
20.1
1198
8997
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
20.0
2345
19385
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
2.1
20.0
230
1110
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
7.5
20.0
47
63
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.6
20.0
478
2957
A41.8
ICD-10 Finland
Other specified sepsis
2.3
20.0
180
775
RT274
NOMESCO Finland
NA
9.8
20.0
40
41
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.8
20.0
343
1922
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.6
19.9
511
3218
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
4.7
19.9
67
142
R07.1
ICD-10 Finland
Chest pain on breathing
2.7
19.8
137
513
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
19.8
629
4179
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
12.5
19.8
35
28
K07
ICPC
Swollen ankles/oedema
1.7
19.7
428
2577
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
19.7
2332
19301
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
19.7
1036
7621
JFB00
NOMESCO Finland
Partial resection of small intestine
2.4
19.6
167
701
R05
ICD-10 Finland
Cough
1.3
19.6
1668
13221
E86
ICD-10 Finland
Volume depletion
2.0
19.5
261
1339
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
19.5
662
4465
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.8
19.4
317
1745
L02BA03
ATC
fulvestrant; parenteral
4.7
19.3
66
142
R03BA01
ATC
beclometasone; inhalant
1.3
19.3
1252
9534
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.0
19.3
233
1148
J20
ICD-10 Finland
Acute bronchitis
1.5
19.2
788
5529
N05AX08
ATC
risperidone; systemic
1.5
19.2
740
5130
WX740
NOMESCO Finland
Nitrogen oxide therapy
7.2
19.1
46
64
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.2
19.1
199
921
R28
ICPC
Limited function/disability (R)
2.6
19.1
138
528
ZXA05
NOMESCO Finland
Left side
1.2
19.1
2506
20981
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
19.0
1033
7641
R4120
NOMESCO Finland
Occupational therapy
1.6
18.9
524
3367
C09AA05
ATC
ramipril; oral
1.2
18.9
2553
21442
R03AK11
ATC
formoterol and fluticasone; inhalant
2.1
18.9
214
1027
L15
ICPC
Knee symptom/complaint
1.3
18.8
1778
14298
SPAT1104
SPAT
Monitoring of emergency patient
1.5
18.7
612
4088
45009
ICD-8 Finland
Pulmonary embolism and infarction, Unspecified
+∞
18.7
18
*
J96.9
ICD-10 Finland
Respiratory failure, unspecified
3.7
18.7
81
218
N05AF03
ATC
chlorprothixene; systemic
2.1
18.7
217
1050
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.2
18.6
185
840
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.9
18.5
277
1482
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
6.2
18.4
49
79
R06.4
ICD-10 Finland
Hyperventilation
2.4
18.4
151
621
A79
ICPC
Malignancy NOS
2.5
18.4
139
549
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.7
18.4
62
132
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
1.9
18.4
255
1328
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.4
18.3
970
7141
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.6
18.3
449
2799
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.4
18.3
779
5504
N19
ICD-10 Finland
Unspecified kidney failure
1.7
18.2
348
2019
SPAT1109
SPAT
Analgesia with portable analgesic pump
3.7
18.2
80
218
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.0
18.2
226
1127
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.5
18.2
604
4052
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.5
18.2
140
557
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
18.2
765
5395
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.7
18.1
80
219
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
2.0
18.1
238
1213
N06AB03
ATC
fluoxetine; oral
1.4
18.1
1020
7583
ZY000
NOMESCO Finland
Hospital inpatient
3.2
18.1
96
303
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
3.5
18.1
86
250
A02BC03
ATC
lansoprazole; oral
1.2
18.1
2841
24232
R31
ICD-10 Finland
Unspecified haematuria
1.4
18.1
981
7251
N06AB06
ATC
sertraline; oral
1.4
18.0
791
5626
TJF80
NOMESCO Finland
Ostomy education
2.9
18.0
109
375
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
17.9
677
4672
WX704
NOMESCO Finland
Intubation
1.5
17.9
584
3902
NF3AA
NOMESCO Finland
Femur X-ray examination
2.1
17.8
194
914
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.5
17.8
642
4386
192
Kela drug reimbursment
Fulvestrant
4.5
17.8
62
137
N03AG01
ATC
valproic acid; systemic, rectal
1.6
17.7
470
2987
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.7
17.7
369
2195
SPAT1211
SPAT
Application of soft bandage
1.4
17.7
789
5629
R03AC12
ATC
salmeterol; inhalant
1.6
17.6
450
2833
J01CA08
ATC
pivmecillinam; oral
1.2
17.6
3431
29894
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.6
17.6
511
3322
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.8
17.6
303
1700
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.2
17.6
177
806
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.1
17.6
197
941
JAH01
NOMESCO Finland
Laparoscopy
1.7
17.6
331
1914
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
17.5
1270
9829
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.5
17.5
137
552
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
180.1
17.5
18
*
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.2
17.5
179
822
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
17.5
157
677
R96
ICPC
Asthma
1.5
17.4
712
4992
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.0
17.4
98
323
S06.0
ICD-10 Finland
Concussion
1.4
17.4
863
6278
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.1
17.3
191
908
A08
ICPC
Swelling
1.7
17.3
389
2368
P03
ICPC
Feeling depressed
1.5
17.3
535
3532
A29
ICPC
General symptom/complaint other
1.4
17.3
995
7427
XF402
NOMESCO Finland
ECG with work load test
1.4
17.2
1030
7733
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
2.6
17.2
121
460
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
4.7
17.2
58
124
P76
ICPC
Depressive disorder
1.7
17.2
381
2310
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
17.2
647
4460
A12BA01
ATC
potassium chloride; oral
1.5
17.1
532
3516
R09.1
ICD-10 Finland
Pleurisy
2.4
17.1
141
584
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.1
17.1
93
300
SPAT1216
SPAT
Assessment of functional ability
1.3
17.1
1527
12171
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.1
17.1
196
947
K56.7
ICD-10 Finland
Ileus, unspecified
2.2
17.1
171
778
R06AE07
ATC
cetirizine; oral
1.2
17.0
3694
32496
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.0
17.0
212
1060
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
2.2
16.9
171
782
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.7
16.9
350
2081
ZXA00
NOMESCO Finland
Right side
1.2
16.9
2668
22736
M10.0
ICD-10 Finland
Idiopathic gout
1.8
16.8
296
1675
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
16.7
955
7117
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.5
16.7
134
547
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
16.7
1195
9229
N05BA12
ATC
alprazolam; oral
1.4
16.7
854
6248
1XC07
NOMESCO Finland
NA
5.7
16.7
47
82
45002
ICD-8 Finland
Pulmonary embolism and infarction, Infarctus
+∞
16.7
16
*
SPAT1234
SPAT
Support of social functional capacity
1.5
16.6
500
3277
ZX112
NOMESCO Finland
Subcutaneous
2.1
16.6
197
963
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.7
16.5
333
1965
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
16.5
789
5701
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
16.4
3651
32162
L03AA14
ATC
lipegfilgrastim; parenteral
2.2
16.4
161
727
TPX15
NOMESCO Finland
Removal of vascular injection port
4.1
16.3
63
154
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.9
16.3
236
1248
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
16.3
629
4356
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
16.3
3951
35074
N06AX21
ATC
duloxetine; oral
1.4
16.3
829
6059
R10.0
ICD-10 Finland
Acute abdomen
1.8
16.2
265
1462
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
16.2
233
1229
45309
ICD-8 Finland
Other venous embolism and thrombosis, NUD (cerebri, cordis, mesenterii, pulmonis exceptis)
5.5
16.2
47
85
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
4.0
16.2
64
160
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
16.2
235
1245
JFF10
NOMESCO Finland
Loop enterostomy
3.7
16.0
70
191
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.8
16.0
289
1647
JMA10
NOMESCO Finland
Transabdominal total splenectomy
3.7
15.9
70
192
L01AX03
ATC
temozolomide; systemic
3.8
15.9
67
178
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
2.9
15.7
97
340
S22.3
ICD-10 Finland
Fracture of rib
1.5
15.7
574
3931
SPAT1125
SPAT
Stoma care and guidance
2.1
15.7
179
865
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.3
15.6
143
626
A02BA02
ATC
ranitidine; systemic
1.2
15.6
1953
16211
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.7
15.6
335
2017
ZX121
NOMESCO Finland
Central venous catheter
4.6
15.6
53
115
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
4.9
15.6
50
102
ZX095
NOMESCO Finland
Combined chemoradiotherapy
3.5
15.5
73
212
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
2.6
15.5
113
438
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
15.4
1751
14372
R33
ICD-10 Finland
Retention of urine
1.4
15.3
770
5609
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
5.9
15.3
42
71
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.6
15.3
108
412
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.7
15.3
107
404
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.9
15.3
92
319
F34.1
ICD-10 Finland
Dysthymia
1.8
15.2
251
1392
R52.2
ICD-10 Finland
Other chronic pain
1.8
15.2
264
1488
F29
ICD-10 Finland
Unspecified nonorganic psychosis
1.9
15.1
226
1211
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.5
15.0
560
3855
L04AD01
ATC
ciclosporin; systemic
2.2
15.0
154
710
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
2.9
15.0
88
300
205
Kela drug reimbursment
Chronic hypertension
1.2
15.0
3061
26706
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.3
15.0
980
7465
M13.9
ICD-10 Finland
Arthritis, unspecified
1.5
15.0
566
3905
C01DA14
ATC
isosorbide mononitrate; oral
1.2
15.0
1788
14758
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
2.8
15.0
98
358
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
2.8
15.0
98
358
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.6
14.9
388
2458
XA800
NOMESCO Finland
Neuropsychological investigation
1.7
14.9
292
1708
XG460
NOMESCO Finland
Short time oxymetry
2.1
14.9
166
794
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
14.9
2642
22738
L02BG06
ATC
exemestane; oral
2.4
14.9
122
503
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.9
14.9
218
1159
B03XA02
ATC
darbepoetin alfa; parenteral
2.1
14.8
170
822
K29
ICPC
Cardiovascular sympt/complt other
1.6
14.8
385
2437
C90.0
ICD-10 Finland
Multiple myeloma
2.5
14.8
117
476
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
2.8
14.8
96
347
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
2.4
14.8
125
526
WX721
NOMESCO Finland
Oxygen concentrator therapy
6.0
14.7
40
67
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
3.8
14.7
62
165
KAC10
NOMESCO Finland
Total nephrectomy with capsule
2.8
14.7
95
343
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
2.9
14.6
90
316
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.5
14.6
485
3260
WF002
NOMESCO Finland
Radical radiotherapy
1.5
14.5
427
2790
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
14.5
459
3050
Z3229
NOMESCO Finland
Other healthcare associate professional
1.4
14.5
767
5641
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.3
14.5
1135
8876
L16
ICPC
Ankle symptom/complaint
1.4
14.5
768
5652
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
14.5
1133
8856
L05
ICPC
Flank/axilla symptom/complaint
1.5
14.5
440
2896
N06AX03
ATC
mianserin; oral
1.6
14.4
412
2669
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
3.8
14.4
60
158
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
14.4
6255
58060
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
2.4
14.4
120
502
JN6AD
NOMESCO Finland
CT of torso and neck
2.4
14.4
117
484
J47
ICD-10 Finland
Bronchiectasis
2.0
14.3
182
917
N02AA01
ATC
morphine; systemic, rectal
2.3
14.3
136
605
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
14.2
246
1387
J86.9
ICD-10 Finland
Pyothorax without fistula
2.7
14.2
94
346
K82
ICPC
Pulmonary heart disease
19.1
14.2
21
11
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.6
14.2
381
2436
J12.8
ICD-10 Finland
Other viral pneumonia
3.1
14.1
78
256
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
4.3
14.1
51
118
J02AC03
ATC
voriconazole; systemic
6.4
14.1
36
56
A03
ICPC
Fever
1.3
14.0
1048
8135
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
2.4
14.0
115
478
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
13.9
1549
12670
A01
ICPC
Pain general/multiple sites
1.4
13.9
645
4630
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
13.9
2665
23080
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
2.2
13.9
142
656
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
5.0
13.9
44
89
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
4.0
13.9
55
139
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.4
13.9
111
456
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
13.9
2486
21397
K92.0
ICD-10 Finland
Haematemesis
1.8
13.8
229
1272
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
1.8
13.8
253
1450
WX320
NOMESCO Finland
Spinalanesthesy
1.2
13.8
2015
16983
N05AD01
ATC
haloperidol; systemic
1.7
13.8
294
1767
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
1.9
13.8
201
1069
369
Kela drug reimbursment
Regorafenib
6.5
13.8
35
54
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.5
13.8
441
2939
B99
ICD-10 Finland
Other and unspecified infectious diseases
1.9
13.7
186
962
R03BB01
ATC
ipratropium bromide; inhalant
1.5
13.7
427
2826
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.8
13.7
224
1242
WX610
NOMESCO Finland
Patient controlled analgesia
3.7
13.7
59
161
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.2
13.7
135
615
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.7
13.6
278
1651
KBV10
NOMESCO Finland
Removal of stent from ureter
3.0
13.6
76
252
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.3
13.6
1068
8353
N05AB03
ATC
perphenazine; systemic, rectal
1.7
13.6
274
1622
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
2.8
13.5
86
310
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
2.6
13.5
100
391
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.5
13.5
424
2812
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.6
13.5
386
2509
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
1.9
13.5
192
1013
XF404
NOMESCO Finland
Ambulatory ECG
1.3
13.4
827
6238
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
2.5
13.4
104
420
R13
ICD-10 Finland
Dysphagia
1.4
13.4
556
3913
ZX090
NOMESCO Finland
Other technic of radiotherapy
1.8
13.4
244
1402
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
5.6
13.4
38
68
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.2
13.4
2375
20414
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.5
13.4
103
414
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.6
13.3
380
2465
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.1
13.3
71
228
R03BA08
ATC
ciclesonide; inhalant
1.4
13.3
616
4425
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
1.9
13.3
207
1126
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
13.3
860
6538
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.3
13.3
121
530
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
4.3
13.2
48
112
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
2.6
13.2
98
384
LCA06
NOMESCO Finland
Biopsy of endometrium
1.4
13.2
775
5803
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.8
13.2
221
1233
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.2
13.2
129
586
XG474
NOMESCO Finland
Exhalation nntrogen oxide
1.9
13.2
194
1038
P99
ICPC
Psychological disorders other
2.0
13.1
164
822
C07AB02
ATC
metoprolol; systemic
1.2
13.1
2192
18720
M01AH02
ATC
rofecoxib; oral
1.3
13.1
1239
9929
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.4
13.1
535
3751
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
1.9
13.1
203
1105
N05AN01
ATC
lithium; oral
2.0
13.1
168
854
L01XX05
ATC
hydroxycarbamide; oral
2.3
13.0
119
520
4538X
ICD-9 Finland
Other venous embolism and thrombosis, Of other specified veins
4.5
13.0
45
100
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.0
13.0
155
765
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
2.7
13.0
90
340
A11CC03
ATC
alfacalcidol; systemic
1.8
13.0
205
1122
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.0
13.0
166
843
M03BX02
ATC
tizanidine; oral
1.2
13.0
5376
49541
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
2.4
13.0
107
445
L02BG04
ATC
letrozole; oral
1.5
13.0
451
3058
J01FA09
ATC
clarithromycin; systemic
1.2
13.0
2549
22109
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.4
13.0
683
5021
SPAT1252
SPAT
Overall medication plan or its review
1.4
13.0
649
4731
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.5
12.9
427
2866
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
12.9
693
5106
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
3.3
12.9
64
195
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.7
12.9
274
1645
AN1
HP
Coronary angiography
1.3
12.9
1189
9502
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.1
12.9
137
646
R5110
SPAT
NA
1.8
12.8
226
1284
R05
ICPC
Cough
1.2
12.8
1775
14870
P01BA02
ATC
hydroxychloroquine; oral
1.4
12.8
643
4686
155
Kela drug reimbursment
Afatinib and gefitinib
7.6
12.8
29
38
J01FA10
ATC
azithromycin; systemic
1.2
12.8
4807
43968
ZX080
NOMESCO Finland
Image guided radiotherapy
1.9
12.7
174
905
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.3
12.7
62
187
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.2
12.7
126
576
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
2.7
12.7
84
310
SPAT1251
SPAT
Organisation of medication
1.6
12.7
352
2270
ZX100
NOMESCO Finland
Oral
2.2
12.7
130
602
F61.0
ICD-10 Finland
Mixed personality disorders
2.3
12.7
114
497
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
2.7
12.6
87
327
176
Kela drug reimbursment
Regorafenib
6.0
12.6
34
57
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.8
12.6
207
1147
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.7
12.6
249
1463
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
2.1
12.6
147
720
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
12.6
238
1380
-50
ICPC
Medication/prescr/renewal
1.6
12.6
365
2379
JKA20
NOMESCO Finland
Cholecystectomy
1.7
12.6
261
1560
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
1.9
12.6
173
905
WVA20
NOMESCO Finland
Medicine administration
1.9
12.5
185
992
N17.8
ICD-10 Finland
Other acute renal failure
2.4
12.5
107
454
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.8
12.5
216
1221
I28.9
ICD-10 Finland
Disease of pulmonary vessels, unspecified
11.0
12.5
23
21
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
3.3
12.5
62
190
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.0
12.5
150
743
SPAT1172
SPAT
Guidance concerning hydration
1.7
12.4
233
1349
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
3.6
12.4
55
154
I50
ICD-10 Finland
Heart failure
1.6
12.4
316
1996
R29
ICPC
Respiratory symptom/complaint other
1.5
12.4
461
3175
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.2
12.4
118
530
M01AX17
ATC
nimesulide; oral
1.2
12.4
2314
19968
I82.80
ICD-10 Finland
Emboli and thrombosis in the subclavian vein
6.0
12.3
33
55
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.6
12.3
339
2181
RS230
NOMESCO Finland
NA
3.7
12.3
53
145
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.0
12.3
71
240
KBV00
NOMESCO Finland
Insertion of stent into ureter
3.2
12.3
64
203
G43.9
ICD-10 Finland
Migraine, unspecified
1.6
12.3
287
1772
X57
ICD-10 Finland
Unspecified privation
1.9
12.3
185
999
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
12.3
848
6511
JJB10
NOMESCO Finland
Atypcal resection of liver
4.9
12.3
39
80
P29
ICPC
Psychological sympt/compl other
1.6
12.2
314
1987
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.7
12.2
271
1650
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
12.2
406
2730
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
1.9
12.2
163
842
XQ902
NOMESCO Finland
Other photography
3.2
12.1
62
194
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
3.3
12.1
59
178
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
4.4
12.1
43
99
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.4
12.1
582
4210
I42.0
ICD-10 Finland
Dilated cardiomyopathy
1.7
12.1
239
1409
N03AF01
ATC
carbamazepine; oral, rectal
1.5
12.1
440
3019
RS220
NOMESCO Finland
NA
2.3
12.1
107
463
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
3.1
12.1
64
206
E66.0
ICD-10 Finland
Obesity due to excess calories
2.4
12.1
104
444
D69.5
ICD-10 Finland
Secondary thrombocytopenia
4.4
12.0
42
95
Z93
ICD-10 Finland
Artificial opening status
4.4
12.0
42
95
N07BC02
ATC
methadone; systemic
4.8
12.0
39
82
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.4
12.0
97
400
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
2.7
12.0
79
291
TAB00
NOMESCO Finland
Lumbar puncture
1.6
12.0
295
1848
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.1
12.0
128
606
N06AA12
ATC
doxepin; systemic
1.5
12.0
470
3273
1501
Kela drug reimbursment
Palbociclib
3.6
11.9
52
144
RD210
NOMESCO Finland
NA
2.1
11.9
129
612
KH1AD
NOMESCO Finland
CT of urinary organs
1.7
11.9
249
1494
M05BA04
ATC
alendronic acid; oral
1.3
11.8
814
6244
K59.09
ICD-10 Finland
Constipation, unspecified
1.4
11.8
527
3762
3AC01
NOMESCO Finland
NA
2.4
11.8
94
388
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
11.7
1987
16971
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
11.7
647
4793
N20.1
ICD-10 Finland
Calculus of ureter
1.6
11.7
304
1929
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.2
11.7
121
563
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
5.2
11.7
35
67
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
2.6
11.7
82
314
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.4
11.7
98
412
S20.2
ICD-10 Finland
Contusion of thorax
1.5
11.7
380
2544
I20.09
ICD-10 Finland
Unstable angina
1.4
11.6
555
4010
I47.2
ICD-10 Finland
Ventricular tachycardia
1.8
11.6
189
1050
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.7
11.6
79
299
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
1.6
11.6
329
2134
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
2.4
11.6
93
385
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
5.7
11.6
32
56
SPAT1097
SPAT
Recording of ECG
1.2
11.6
1352
11110
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
1.9
11.6
163
862
Z00.0
ICD-10 Finland
General medical examination
1.2
11.5
1529
12737
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.2
11.5
117
540
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.2
11.5
114
520
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
2.6
11.5
84
328
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
2.6
11.5
81
312
R06
ICD-10 Finland
Abnormalities of breathing
2.6
11.5
81
312
318
Kela drug reimbursment
Teriparatide
3.3
11.5
56
170
K81.0
ICD-10 Finland
Acute cholecystitis
1.8
11.5
178
972
394
Kela drug reimbursment
Palbociclib
3.7
11.5
49
134
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
1.8
11.4
189
1052
PHD99
NOMESCO Finland
Resection of other vein
1.4
11.4
494
3505
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
1.9
11.4
155
806
M48.0
ICD-10 Finland
Spinal stenosis
1.3
11.4
1143
9225
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.5
11.4
348
2298
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.5
11.3
435
3016
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.3
11.3
97
415
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
11.3
296
1882
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.0
11.3
139
697
P01
ICPC
Feeling anxious/nervous/tense
1.4
11.3
502
3583
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
11.3
2234
19360
O22.3
ICD-10 Finland
Deep phlebothrombosis in pregnancy
10.5
11.2
21
20
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
3.1
11.2
60
195
H05AA02
ATC
teriparatide; parenteral
3.4
11.2
52
152
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.6
11.2
279
1753
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.2
11.2
113
523
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.5
11.2
373
2511
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.4
11.2
517
3718
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
3.8
11.2
46
122
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.3
11.2
101
443
N05CF02
ATC
zolpidem; oral
1.2
11.1
1384
11449
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
1.8
11.1
175
962
Z94.2
ICD-10 Finland
Lung transplant status
6.8
11.1
27
40
J43.9
ICD-10 Finland
Emphysema, unspecified
2.0
11.1
140
711
N03AX11
ATC
topiramate; oral
1.9
11.1
150
779
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.8
11.1
180
997
L03
ICPC
Low back symptom/complaint
1.2
11.1
1919
16423
L03.9
ICD-10 Finland
Cellulitis, unspecified
1.9
11.0
164
882
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
3.4
11.0
51
149
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.4
11.0
580
4266
SPAT1167
SPAT
Insertion of urinary catheter
1.6
11.0
310
2007
I25.2
ICD-10 Finland
Old myocardial infarction
1.3
10.9
709
5390
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
1.6
10.9
286
1822
197
Kela drug reimbursment
Sunitinib
4.0
10.9
42
105
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.6
10.9
256
1583
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
2.6
10.9
78
304
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.3
10.9
102
455
Z94.0
ICD-10 Finland
Kidney transplant status
2.4
10.9
88
366
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.7
10.9
217
1285
Z72.2
ICD-10 Finland
Drug use
4.2
10.9
40
96
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.3
10.8
93
398
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.1
10.8
119
569
ZXA10
NOMESCO Finland
Bilateral
1.2
10.8
1683
14253
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.1
10.7
112
526
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.0
10.7
139
711
UJK02
NOMESCO Finland
ERCP
1.7
10.7
221
1321
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
4.0
10.7
41
102
D45
ICD-10 Finland
Polycythaemia vera
2.3
10.7
92
393
M81.4
ICD-10 Finland
Drug-induced osteoporosis
3.5
10.7
48
137
GD1FQ
NOMESCO Finland
Lung ventilation SPECT with low dose CT
28.0
10.7
14
5
N03AF02
ATC
oxcarbazepine; oral
1.7
10.7
227
1367
N05AH02
ATC
clozapine; systemic
2.1
10.7
114
541
JFB46
NOMESCO Finland
Resection of sigmoid colon
2.1
10.7
111
520
NB6AA
NOMESCO Finland
Humerus X-ray examination
1.8
10.7
167
915
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.6
10.7
247
1523
PH2ST
NOMESCO Finland
Endovascular thrombolysis of pelvic and lower leg veins with radiological guidance
21.4
10.7
15
7
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
4.1
10.6
40
98
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
1.9
10.6
155
829
H03AA01
ATC
levothyroxine sodium; systemic
1.2
10.6
1990
17149
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.6
10.6
163
2683
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
1.7
10.6
235
1433
Z29.0
ICD-10 Finland
Isolation
3.5
10.6
47
133
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
3.8
10.6
43
113
RS222
NOMESCO Finland
NA
2.2
10.6
108
502
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
3.1
10.6
55
176
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.4
10.6
446
3155
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.3
10.5
808
6293
L01XE33
ATC
[U] palbociclib; oral
4.0
10.5
40
99
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.3
10.5
930
7386
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
1.9
10.5
138
712
M79.1
ICD-10 Finland
Myalgia
1.3
10.5
922
7314
GDC00
NOMESCO Finland
Lobectomy of lung
2.7
10.5
68
251
I82.21
ICD-10 Finland
Emboli and thrombosis in the inferior vena cava
9.1
10.5
21
23
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.3
10.5
674
5122
RK110
NOMESCO Finland
NA
2.5
10.5
79
318
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
1.9
10.4
147
775
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.1
10.4
115
554
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.0
10.4
130
655
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
1.8
10.4
169
938
T90
ICPC
Diabetes non-insulin dependent
1.2
10.4
2072
17951
M79.7
ICD-10 Finland
Fibromyalgia
1.7
10.3
203
1196
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.1
10.3
111
527
M25.5
ICD-10 Finland
Pain in joint
1.2
10.3
2200
19166
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
2.7
10.3
67
248
UJD02
NOMESCO Finland
Gastroscopy
1.4
10.3
417
2926
RF210
NOMESCO Finland
NA
1.7
10.3
213
1275
P15
ICPC
Chronic alcohol abuse
1.8
10.3
177
1001
R05FB02
ATC
cough suppressants and expectorants
1.1
10.3
3594
32542
Z01.7
ICD-10 Finland
Laboratory examination
1.3
10.3
863
6808
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
2.5
10.3
80
326
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.5
10.3
317
2102
RK250
NOMESCO Finland
NA
3.1
10.3
53
169
RK320
NOMESCO Finland
NA
2.3
10.2
87
372
C02KX01
ATC
bosentan; oral
10.6
10.2
19
18
L01XE04
ATC
[U] sunitinib; oral
4.3
10.2
36
83
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.4
10.2
409
2862
ZYC01
NOMESCO Finland
Remote contact by phone
1.5
10.2
306
2016
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.6
10.2
289
1879
A10BA02
ATC
metformin; oral
1.2
10.2
2651
23473
M10
ICD-10 Finland
Gout
1.5
10.2
359
2449
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
1.9
10.1
153
830
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
3.0
10.1
58
196
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
2.0
10.1
130
666
ZXD35
NOMESCO Finland
Usual procedure
1.6
10.1
278
1794
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.7
10.1
204
1213
E87.5
ICD-10 Finland
Hyperkalaemia
1.8
10.1
158
866
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
2.8
10.1
64
233
C03AA03
ATC
hydrochlorothiazide; oral
1.3
10.1
916
7302
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
3.1
10.1
52
166
R01
ICPC
Pain respiratory system
2.1
10.0
109
521
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
10.0
1889
16275
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
3.4
10.0
46
135
SPAT1281
SPAT
Other administrative function
1.3
9.9
628
4760
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
3.0
9.9
57
193
UJF92
NOMESCO Finland
Capsular endoscopy
1.9
9.9
147
793
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.5
9.9
313
2087
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
2.4
9.9
82
347
PD5BD
NOMESCO Finland
Extensive CT of aorta
1.7
9.9
179
1031
PHM77
NOMESCO Finland
Endovenous obliteration of v.saphena parva
2.4
9.9
79
329
TJA10
NOMESCO Finland
Laparocentesis
4.0
9.8
38
96
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
4.9
9.8
31
64
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.6
9.8
253
1605
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.5
9.8
340
2312
1BA04
NOMESCO Finland
NA
6.3
9.8
25
40
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
1.9
9.8
138
731
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
4.0
9.8
37
92
XF640
NOMESCO Finland
NA
1.6
9.8
257
1642
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.2
9.7
99
459
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.6
9.7
263
1688
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.5
9.7
353
2428
K08.3
ICD-10 Finland
Retained dental root
1.4
9.7
558
4170
R24
ICPC
Haemoptysis
2.8
9.7
58
205
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.3
9.6
620
4713
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.5
9.6
371
2581
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.6
9.6
223
1380
XG405
NOMESCO Finland
Education on PEF monitoring
2.0
9.6
119
600
J01CF05
ATC
flucloxacillin; systemic
1.5
9.6
271
1763
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
1.8
9.6
156
870
Z2445
NOMESCO Finland
Psychologist
1.6
9.6
221
1365
L01XE21
ATC
[U] regorafenib; oral
6.8
9.6
23
34
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
6.8
9.6
23
34
WX212
NOMESCO Finland
Femoral plexus blockade
1.8
9.6
167
952
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.0
9.5
110
540
W10
ICD-10 Finland
Fall on and from stairs and steps
1.4
9.5
387
2718
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
9.5
953
7687
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.4
9.5
398
2813
341
Kela drug reimbursment
Afatinib and gefitinib
15.0
9.5
15
10
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
2.7
9.5
62
231
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
2.3
9.5
87
387
M54.8
ICD-10 Finland
Other dorsalgia
1.5
9.5
271
1767
JFB30
NOMESCO Finland
Right hemicolectomy
1.9
9.5
139
747
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.5
9.5
340
2332
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
1.5
9.4
280
1842
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
1.9
9.4
139
750
FKE05
NOMESCO Finland
Mitral valvuloplasty
100.1
9.4
10
*
I81
ICD-10 Finland
Portal vein thrombosis
3.5
9.4
42
121
115
Kela drug reimbursment
Breast cancer
1.3
9.4
604
4593
F60.9
ICD-10 Finland
Personality disorder, unspecified
2.3
9.4
80
342
I27.1
ICD-10 Finland
Kyphoscoliotic heart disease
12.3
9.3
16
13
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
1.7
9.3
186
1102
E83.50
ICD-10 Finland
Hypercalcemia
2.1
9.3
106
518
R99
ICPC
Respiratory disease other
1.9
9.3
136
732
SPAT1060
SPAT
Administration of oxygen
3.1
9.3
48
154
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.3
9.3
682
5283
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.2
9.3
1232
10261
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.3
9.3
746
5852
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
1.7
9.3
168
970
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
3.2
9.2
47
149
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.4
9.2
407
2904
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
2.2
9.2
88
398
C09AA02
ATC
enalapril; systemic
1.2
9.2
1988
17319
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
4.2
9.2
33
78
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
1.9
9.2
135
724
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.3
9.2
585
4438
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
3.4
9.2
43
128
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.5
9.2
300
2014
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
3.1
9.2
48
155
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
7.2
9.2
21
29
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.7
9.2
190
1139
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
6.0
9.2
24
40
JEA00
NOMESCO Finland
Appendectomy
1.4
9.2
431
3113
PH2BC
NOMESCO Finland
Extensive flebography of lower extremity with X-ray
13.6
9.2
15
11
PH7YT
NOMESCO Finland
Dilatation of inferior vena cava or lower extremity vein with stent
13.6
9.2
15
11
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
2.7
9.2
59
218
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
9.1
2284
20139
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.3
9.1
556
4188
L01AA01
ATC
cyclophosphamide; systemic
3.1
9.1
48
156
A99
ICPC
Disease/condition unspecnature/site
1.3
9.1
631
4845
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
9.1
179
1057
GBB00
NOMESCO Finland
Tracheostomy
2.1
9.1
102
495
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
4.1
9.1
34
84
A12AA04
ATC
calcium carbonate; oral
1.9
9.1
132
708
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.5
9.1
288
1924
R05FA02
ATC
opium derivatives and expectorants; systemic
1.1
9.1
3627
33079
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
1.7
9.1
177
1046
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
2.8
9.0
57
206
Z02.7
ICD-10 Finland
Issue of medical certificate
1.4
9.0
468
3440
N06AX05
ATC
trazodone; oral
1.7
9.0
171
1001
M70.6
ICD-10 Finland
Trochanteric bursitis
1.2
9.0
959
7795
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.8
9.0
513
6674
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.2
9.0
1336
11253
ZX050
NOMESCO Finland
Stereotactic radiotherapy
2.5
9.0
65
256
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
2.7
9.0
58
215
K56.0
ICD-10 Finland
Paralytic ileus
2.2
9.0
87
399
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
2.5
9.0
69
282
R01AD08
ATC
fluticasone; nasal
1.2
9.0
2177
19151
WX723
NOMESCO Finland
CPAP therapy
1.6
8.9
237
1517
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
2.5
8.9
68
274
PG1ST
NOMESCO Finland
Endovascular arterial thrombolysis with radiological guidance not elsewhere classified
4.8
8.9
28
58
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
4.2
8.9
32
76
R04
ICPC
Breathing problem other
1.5
8.9
254
1653
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
8.9
2242
19776
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.5
8.9
257
1678
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
1.8
8.9
139
766
N06AB05
ATC
paroxetine; oral
1.4
8.9
402
2882
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
6.1
8.9
23
38
SPAT1310
SPAT
Counselling related to known health issue
1.2
8.9
2732
24467
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
2.7
8.9
58
217
WW200
SPAT
NA
0.7
8.9
425
5660
L89
ICD-10 Finland
Decubitus ulcer and pressure area
1.8
8.9
157
900
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.4
8.9
429
3115
TK810
NOMESCO Finland
Hemofiltration
2.8
8.9
56
203
1220
FHL
Arthroscopy
1.5
8.9
315
2158
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
1.9
8.8
116
602
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
2.6
8.8
60
227
212
Kela drug reimbursment
Gout
1.7
8.8
190
1154
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
1.9
8.8
126
674
R23.3
ICD-10 Finland
Spontaneous ecchymoses
1.7
8.8
158
908
PD5AD
NOMESCO Finland
CT of aorta
1.8
8.8
132
718
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.4
8.8
346
2418
I95.1
ICD-10 Finland
Orthostatic hypotension
1.5
8.8
314
2149
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.4
8.8
458
3368
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
8.8
1401
11878
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
4.9
8.8
27
55
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
8.8
640
4958
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
2.7
8.8
58
219
JFF23
NOMESCO Finland
Transversostomy
2.1
8.7
95
457
ZX114
NOMESCO Finland
Intramuscular
2.0
8.7
109
555
159
Kela drug reimbursment
Pazopanib
4.5
8.7
29
64
I95.9
ICD-10 Finland
Hypotension, unspecified
1.9
8.7
121
640
Z50.1
ICD-10 Finland
Other physical therapy
1.4
8.7
443
3243
N06AA10
ATC
nortriptyline; systemic
1.8
8.7
150
854
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.2
8.7
82
372
M25.0
ICD-10 Finland
Haemarthrosis
2.1
8.7
89
417
N05CD02
ATC
nitrazepam; oral
1.7
8.7
171
1012
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.5
8.7
251
1643
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.1
8.7
92
439
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
2.9
8.6
51
179
D07AA02
ATC
hydrocortisone; topical
1.2
8.6
1005
8249
I45.9
ICD-10 Finland
Conduction disorder, unspecified
2.1
8.6
92
440
GDG10
NOMESCO Finland
Bilateral transplantation of lung
6.6
8.6
21
32
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
1.8
8.6
132
721
8480/3-C18.1
ICD-O-3
Mucinous adenocarcinoma of appendix
7.6
8.6
19
25
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
1.7
8.6
165
970
JFF13
NOMESCO Finland
Terminal enterostomy
4.3
8.6
30
70
J01MA01
ATC
ofloxacin; systemic
1.3
8.6
760
6040
L01XE13
ATC
[U] afatinib; oral
8.2
8.5
18
22
A10AE04
ATC
insulin glargine; parenteral
1.3
8.5
771
6141
C02KX02
ATC
ambrisentan; oral
16.3
8.5
13
8
RF120
NOMESCO Finland
NA
2.1
8.5
91
435
R06.5
ICD-10 Finland
Mouth breathing
1.3
8.5
595
4578
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.4
8.5
338
2368
J01DA06
ATC
[U] cefuroxime; systemic
1.2
8.5
1152
9612
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
2.2
8.5
80
360
C20
ICD-10 Finland
Malignant neoplasm of rectum
2.3
8.5
75
329
D86.0
ICD-10 Finland
Sarcoidosis of lung
2.0
8.5
100
498
XF620
NOMESCO Finland
Examination of circulation with color method
3.0
8.5
45
148
M54
ICD-10 Finland
Dorsalgia
1.3
8.5
784
6268
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
1.7
8.4
155
900
M09AX01
ATC
hyaluronic acid; parenteral
1.4
8.4
470
3497
3012
Kela drug reimbursment
Cabozantinib
4.5
8.4
28
62
SPAT1276
SPAT
Outlining of treatment with patient or their family members
1.6
8.4
191
1175
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2.4
8.4
69
292
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
5.1
8.4
25
49
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.3
8.4
75
331
R51
ICD-10 Finland
Headache
1.5
8.4
321
2231
K22.1
ICD-10 Finland
Ulcer of oesophagus
1.7
8.4
153
886
C09CA01
ATC
losartan; oral
1.2
8.4
2177
19236
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.3
8.4
772
6165
322
Kela drug reimbursment
Sunitinib
5.6
8.4
23
41
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.0
8.4
95
466
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
2.8
8.4
50
177
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.3
8.4
584
4495
M54.4
ICD-10 Finland
Lumbago with sciatica
1.2
8.4
1188
9958
PH2AE
SPAT
NA
2.3
8.4
74
324
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
1.9
8.4
122
657
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.3
8.4
516
3900
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
1.5
8.3
246
1618
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
2.1
8.3
89
423
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
6.7
8.3
20
30
WX726
NOMESCO Finland
High-flow oxygen therapy
6.7
8.3
20
30
1AE03
NOMESCO Finland
NA
+∞
8.3
8
*
G72.8
ICD-10 Finland
Other specified myopathies
1.8
8.3
135
753
JAF10
NOMESCO Finland
Repair of umbilical hernia
1.7
8.3
171
1025
R40.2
ICD-10 Finland
Coma, unspecified
2.1
8.3
84
392
J01DA08
ATC
[U] cefaclor; oral
1.3
8.3
645
5040
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.6
8.3
225
1454
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.5
8.3
260
1734
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
1.8
8.3
137
772
B03BA03
ATC
hydroxocobalamin; parenteral
1.3
8.2
530
4032
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
3.1
8.2
43
140
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
2.9
8.2
48
167
1502
Kela drug reimbursment
Cabozantinib
4.4
8.2
28
64
R84
ICPC
Malignant neoplasm bronchus/lung
3.0
8.2
45
152
F10.20
ICD-10 Finland
Alcohol dependence currently independent
1.8
8.2
134
750
AP2
HP
Catheterization of the right side of the heart
2.9
8.2
47
161
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.3
8.2
471
3524
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
2.1
8.2
86
410
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
1.8
8.2
138
783
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
1.6
8.1
180
1103
D01
ICPC
Abdominal pain/cramps general
1.3
8.1
715
5676
C07AA05
ATC
propranolol; systemic
1.2
8.1
1402
11973
A09AA02
ATC
multienzymes (lipase, protease etc.)
1.7
8.1
154
903
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
4.1
8.1
30
74
WX780
NOMESCO Finland
Remote monitoring CPAP
1.5
8.1
254
1694
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
1.7
8.1
171
1033
H05BX01
ATC
cinacalcet; oral
2.6
8.1
56
216
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
3.0
8.1
43
142
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
2.8
8.1
48
170
F10.25
ICD-10 Finland
Alcohol dependence continuous use
1.9
8.1
116
623
RS121
NOMESCO Finland
NA
2.7
8.1
53
200
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.3
8.0
671
5291
C56
ICD-10 Finland
Malignant neoplasm of ovary
2.9
8.0
47
164
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
2.3
8.0
72
319
A10BH05
ATC
linagliptin; oral
1.4
8.0
410
3005
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
2.0
8.0
101
517
103
Kela drug reimbursment
Diabetes, insulin-treated
1.1
8.0
2549
22855
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
3.4
8.0
36
105
P72
ICPC
Schizophrenia
1.9
8.0
111
587
N06AX26
ATC
vortioxetine; oral
1.4
8.0
320
2246
SPAT1153
SPAT
Removal of sutures
1.1
8.0
2861
25861
M01AH01
ATC
celecoxib; oral (coxibs)
1.2
8.0
1558
13451
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
5.0
8.0
24
48
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.1
8.0
84
399
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
3.3
8.0
37
111
B37.7
ICD-10 Finland
Candidal sepsis
5.5
7.9
22
40
WW300
NOMESCO Finland
Transfer of autologic stem cells
3.2
7.9
39
122
K51.5
ICD-10 Finland
Left sided colitis
1.7
7.9
171
1040
WX600
NOMESCO Finland
Single shot through catheter
2.0
7.9
98
498
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
2.2
7.9
72
322
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.5
7.9
223
1454
M31.3
ICD-10 Finland
Wegener granulomatosis
3.3
7.9
38
117
M03BX01
ATC
baclofen; systemic
1.8
7.9
124
685
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
3.0
7.9
42
139
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
1.8
7.9
122
671
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.3
7.9
694
5513
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.0
7.9
97
491
M89.0
ICD-10 Finland
Algoneurodystrophy
2.5
7.9
58
232
-60
ICPC
Result test/procedure
1.3
7.8
466
3505
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.3
7.8
713
5688
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.8
7.8
690
8515
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
1.7
7.8
165
999
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
2.1
7.8
79
371
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
6.1
7.8
20
33
I20.00
ICD-10 Finland
Unstable angina
1.4
7.8
300
2091
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
1.7
7.8
154
913
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.4
7.8
324
2291
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
3.2
7.8
39
124
4549X
ICD-9 Finland
Varicose veins of lower extremities, Without mention of ulcer or inflammation
1.4
7.8
441
3293
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
1.8
7.8
136
779
K65.0
ICD-10 Finland
Acute peritonitis
2.0
7.7
97
497
SPAT1094
SPAT
Continuous Positive Airway Pressure
2.1
7.7
87
424
EBA10
NOMESCO Finland
Surgical removal of tooth
1.3
7.7
686
5453
U05
ICPC
Urination problems other
1.4
7.7
365
2644
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.4
7.7
362
2615
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
3.5
7.7
34
98
X76
ICPC
Malignant neoplasm breast female
1.8
7.7
132
751
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.1
7.7
83
400
J01MA06
ATC
norfloxacin; oral
1.2
7.7
1160
9776
L01CB01
ATC
etoposide; systemic
2.8
7.7
47
170
ZXD00
NOMESCO Finland
Emergency procedure
1.5
7.7
234
1553
158
Kela drug reimbursment
Everolimus
6.3
7.7
19
30
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
2.5
7.7
57
229
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.2
7.7
814
6618
G44.2
ICD-10 Finland
Tension-type headache
1.2
7.6
912
7507
M01AX05
ATC
glucosamine; oral
1.2
7.6
1906
16782
D50.8
ICD-10 Finland
Other iron deficiency anaemias
1.9
7.6
100
520
Z31.5
ICD-10 Finland
Genetic counselling
1.5
7.6
266
1817
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
3.4
7.6
34
99
KH1AA
NOMESCO Finland
Urinary tract X-ray examination without contrast
1.9
7.6
100
521
A98
ICPC
Health maint/preventive medicine
0.9
7.6
9271
95126
X77
ICPC
Malignant neopl genital female other
3.5
7.6
33
94
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
2.5
7.6
57
231
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
1.7
7.6
149
884
XF612
NOMESCO Finland
Measurement of central venous pressure
3.6
7.6
32
89
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
2.7
7.6
50
189
A07EC01
ATC
sulfasalazine; oral, rectal
1.3
7.6
600
4701
S10
ICPC
Boil/carbuncle
1.4
7.6
371
2703
Z93.2
ICD-10 Finland
Ileostomy status
3.1
7.6
38
121
H26.3
ICD-10 Finland
Drug-induced cataract
2.6
7.6
50
190
ZZA00
NOMESCO Finland
Split skin graft
1.5
7.5
247
1664
Z51.0
ICD-10 Finland
Radiotherapy session
1.9
7.5
97
501
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.2
7.5
871
7148
KCC10
NOMESCO Finland
Cystoprostatectomy
2.7
7.5
49
184
S76
ICPC
Skin infection other
1.4
7.5
378
2765
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
6.1
7.5
19
31
JG1CG
NOMESCO Finland
Extensive MRI of rectum
2.6
7.5
50
191
LCD00
NOMESCO Finland
Hysterectomy
1.4
7.5
303
2130
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.5
7.5
254
1726
SPAT1307
SPAT
Psychosocial counselling and guidance
1.5
7.5
276
1909
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
2.3
7.5
65
283
ED1AA
NOMESCO Finland
Mandipular X-ray examination
2.6
7.5
52
201
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
2.0
7.5
94
479
J94.2
ICD-10 Finland
Haemothorax
3.3
7.5
35
106
M54.6
ICD-10 Finland
Pain in thoracic spine
1.4
7.5
427
3190
A11
ICPC
Chest pain NOS
1.3
7.5
603
4739
R95
ICPC
Chron obstructive pulmonary disease
1.5
7.5
210
1371
N02AA03
ATC
hydromorphone; systemic, rectal
3.4
7.5
34
101
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
7.5
88
441
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
1.6
7.4
184
1162
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.5
7.4
214
1403
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.3
7.4
530
4094
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
1.7
7.4
154
928
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
1.9
7.4
96
497
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.4
7.4
370
2707
S80.0
ICD-10 Finland
Contusion of knee
1.3
7.4
434
3257
M01AE02
ATC
naproxen; oral, rectal
1.1
7.4
4937
46282
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.4
7.4
289
2019
RF420
NOMESCO Finland
NA
1.9
7.4
98
512
196
Kela drug reimbursment
Paricalcitol and cinacalcet
2.9
7.4
43
150
R52.1
ICD-10 Finland
Chronic intractable pain
2.3
7.4
64
278
G82.2
ICD-10 Finland
Paraplegia, unspecified
3.0
7.4
40
135
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
1.8
7.4
116
645
JG1BG
NOMESCO Finland
MRI of rectum
2.4
7.4
58
240
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
5.3
7.4
21
40
OAB72
NOMESCO Finland
Weight control and weight loss guidance
3.2
7.4
36
113
WF001
NOMESCO Finland
Preoperative radiotherapy
2.1
7.3
73
341
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
5.6
7.3
20
36
XKD00
NOMESCO Finland
Uroflowmetry
1.2
7.3
1454
12565
J05AB11
ATC
valaciclovir; oral
1.2
7.3
978
8147
L86
ICPC
Back syndrome with radiating pain
1.4
7.3
406
3020
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.3
7.3
537
4168
QBA10
NOMESCO Finland
Incision of skin of trunk
2.0
7.3
84
415
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.4
7.3
299
2111
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
1.8
7.3
113
623
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.6
7.3
200
1297
PHM76
NOMESCO Finland
Endovenous obliteration of v.saphena magna
1.5
7.3
223
1482
FB1CC
NOMESCO Finland
Very extensive angiography of arteria pulmonalis
+∞
7.3
7
*
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
1.8
7.3
126
719
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
1.8
7.3
119
670
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
1.6
7.3
166
1029
HAC20
NOMESCO Finland
Total mastectomy
1.4
7.3
304
2154
SPAT1243
SPAT
Psychiatric/psychological examination
1.8
7.3
126
722
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.5
7.2
233
1565
F32
ICD-10 Finland
Depressive episode
1.4
7.2
294
2072
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.3
7.2
456
3462
A91
ICPC
Abnormal result investigation NOS
1.4
7.2
315
2251
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
2.9
7.2
40
137
RK310
NOMESCO Finland
NA
5.8
7.2
19
33
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
2.1
7.2
76
363
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
2.4
7.2
57
238
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.8
7.2
1000
11797
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
7.3
7.2
16
22
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
1.4
7.1
382
2826
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
4.1
7.1
26
64
J01FA15
ATC
telithromycin; oral
1.3
7.1
715
5774
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.2
7.1
809
6622
PH7UT
NOMESCO Finland
Removal of thrombosis from vein of lower extremity or pelvis or from vena cava inferior
30.0
7.1
9
*
NG1DA
NOMESCO Finland
X-ray of knees
1.7
7.1
132
771
B01AC11
ATC
iloprost; inhalant, parenteral
20.0
7.1
10
5
O22.8
ICD-10 Finland
Other venous complications in pregnancy
20.0
7.1
10
5
Z93.3
ICD-10 Finland
Colostomy status
2.1
7.1
71
332
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.3
7.1
595
4700
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
2.3
7.1
63
279
N05BA02
ATC
chlordiazepoxide; systemic
1.6
7.1
182
1159
M54.3
ICD-10 Finland
Sciatica
1.3
7.1
425
3200
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
2.9
7.1
39
133
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
1.8
7.1
104
565
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
2.4
7.1
54
222
A08AB01
ATC
orlistat; oral
2.2
7.1
68
312
5119X
ICD-9 Finland
Pleurisy, Unspecified pleural effusion
3.0
7.1
37
122
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
2.5
7.1
50
197
PD1CD
NOMESCO Finland
Very extensive CT of abdominal aorta and branches
2.9
7.1
41
143
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
1.9
7.1
93
485
1DC02
NOMESCO Finland
NA
3.0
7.1
38
128
PH2AC
NOMESCO Finland
Flebography of lower extremity with X-ray
5.6
7.0
19
34
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
1.3
7.0
408
3060
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
3.6
7.0
29
80
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
2.1
7.0
77
373
R25.1
ICD-10 Finland
Tremor, unspecified
1.5
7.0
214
1425
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
1.8
7.0
120
684
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
1.5
7.0
220
1474
M01AB01
ATC
indometacin; systemic, rectal
1.3
7.0
701
5661
N91.1
ICD-10 Finland
Secondary amenorrhoea
2.4
7.0
53
217
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
4.3
7.0
24
56
J04AB02
ATC
rifampicin; systemic
1.9
7.0
95
503
YNB10
NOMESCO Finland
Collection of stem cells for transplant
4.7
7.0
22
47
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
1.6
7.0
163
1017
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
3.1
7.0
36
118
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
2.4
6.9
56
237
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
2.2
6.9
64
287
F05.9
ICD-10 Finland
Delirium, unspecified
1.6
6.9
169
1063
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
1.9
6.9
90
467
R77.0
ICD-10 Finland
Abnormality of albumin
4.9
6.9
21
43
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
1.6
6.9
185
1191
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
1.9
6.9
98
523
F10.09
ICD-10 Finland
Alcohol intoxication UNS
1.7
6.9
130
761
NK6AN
NOMESCO Finland
Total body bone isotope imaging
1.5
6.9
225
1519
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
2.2
6.9
62
277
B59
ICD-10 Finland
Pneumocystosis
6.3
6.9
17
27
S16
ICPC
Bruise/contusion
1.5
6.9
232
1575
N04AA02
ATC
biperiden; systemic
1.7
6.9
139
834
P16
ICPC
Acute alcohol abuse
1.9
6.9
94
497
S82.1
ICD-10 Finland
Fracture of upper end of tibia
1.7
6.9
123
712
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.2
6.9
1003
8427
S70.0
ICD-10 Finland
Contusion of hip
1.4
6.9
288
2041
I46.9
ICD-10 Finland
Cardiac arrest, unspecified
2.5
6.9
49
194
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
1.6
6.9
162
1010
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
1.5
6.9
226
1528
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
1.5
6.9
245
1683
N30
ICD-10 Finland
Cystitis
1.3
6.9
508
3947
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
7.5
6.9
15
20
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.3
6.9
433
3286
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
3.4
6.9
31
92
C50.99
ICD-10 Finland
Breast, unspecified
1.5
6.9
192
1253
Z73.9
ICD-10 Finland
Problem related to life-management difficulty, unspecified
2.4
6.8
55
232
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
3.6
6.8
28
77
NA2AD
NOMESCO Finland
Thoracic spine CT examination
2.5
6.8
50
203
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.3
6.8
563
4440
Y94.0
ICD-10 Finland
Accident at home
1.6
6.8
148
906
R03DC01
ATC
zafirlukast; oral
1.7
6.8
129
760
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
2.3
6.8
56
241
JAL00
NOMESCO Finland
Biopsy of peritoneum
2.6
6.8
45
172
K80.8
ICD-10 Finland
Other cholelithiasis
1.8
6.8
116
660
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
10.9
6.8
12
11
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
2.4
6.8
55
234
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.2
6.8
827
6829
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
4.1
6.8
24
58
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
4.1
6.8
24
58
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.0
6.8
82
414
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.3
6.8
484
3743
-69
ICPC
Other reason for encounter NEC
1.4
6.7
300
2154
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
1.5
6.7
215
1444
D73.5
ICD-10 Finland
Infarction of spleen
4.5
6.7
22
49
G04CA02
ATC
tamsulosin; oral
1.1
6.7
2198
19719
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
3.1
6.7
34
110
A07EC02
ATC
mesalazine; oral, rectal
1.4
6.7
366
2716
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.2
6.7
753
6162
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
1.9
6.7
96
516
TQW99
NOMESCO Finland
Other minor procedure on skin
1.3
6.7
400
3016
Z92.1
ICD-10 Finland
Personal history of long-term (current) use of anticoagulants
4.7
6.7
21
45
JAH33
NOMESCO Finland
Opening of laparostomy
4.7
6.7
21
45
L01XE10
ATC
[U] everolimus; oral
7.1
6.7
15
21
343
Kela drug reimbursment
Pazopanib
7.1
6.7
15
21
TGD00
NOMESCO Finland
Needle biopsy of lung
2.5
6.7
49
199
SPAT1202
SPAT
Intra-articular injection
1.4
6.7
258
1802
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
1.8
6.7
112
638
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
3.0
6.7
36
122
JAQ10
NOMESCO Finland
Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity
22.5
6.7
9
*
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
4.1
6.7
24
59
T81.9
ICD-10 Finland
Unspecified complication of procedure
1.7
6.7
126
743
I82
ICD-10 Finland
Other venous embolism and thrombosis
3.5
6.6
28
79
S36.0
ICD-10 Finland
Injury of spleen
3.9
6.6
25
64
L01XE03
ATC
[U] erlotinib; oral
3.7
6.6
27
74
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
1.5
6.6
200
1326
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
1.9
6.6
94
506
L04AX05
ATC
pirfenidone; oral
3.3
6.6
31
95
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2.5
6.6
47
186
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.3
6.6
579
4604
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.5
6.6
234
1608
R2110
NOMESCO Finland
Giving the first information
1.3
6.6
458
3527
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
2.1
6.6
67
316
L02BG03
ATC
anastrozole; oral
1.7
6.6
127
752
WX213
NOMESCO Finland
Lower leg blockade
2.2
6.6
60
271
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
1.9
6.6
94
508
QDA10
NOMESCO Finland
Incision of skin of lower limb
2.1
6.6
65
304
A08AA02
ATC
fenfluramine; oral (centrally acting antiobesity products)
1.9
6.6
83
427
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.5
6.6
195
1289
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
5.5
6.6
18
33
KA3EB
NOMESCO Finland
Antegrade pyelography
2.5
6.6
47
187
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
2.0
6.6
81
414
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.3
6.6
531
4174
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
2.2
6.6
62
284
1CX08
NOMESCO Finland
NA
2.6
6.6
44
170
JFB20
NOMESCO Finland
Ileocaecal resection
2.6
6.6
43
163
SPAT1111
SPAT
Planning of analgesia
1.9
6.6
93
499
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
3.5
6.6
28
80
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.3
6.5
434
3322
J01XX08
ATC
linezolid; systemic
2.5
6.5
47
188
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.0
6.5
79
402
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.3
6.5
371
2773
R78
ICPC
Acute bronchitis/bronchiolitis
1.6
6.5
150
931
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.5
6.5
185
1210
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
2.2
6.5
61
276
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
1.7
6.5
133
800
M31.1
ICD-10 Finland
Thrombotic microangiopathy
4.8
6.5
20
42
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
3.1
6.5
32
102
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.1
6.5
71
346
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
2.1
6.5
71
346
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
2.0
6.5
76
382
284
Kela drug reimbursment
Nintedanib and pirfenidone
2.7
6.5
40
148
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.2
6.5
894
7475
I47.1
ICD-10 Finland
Supraventricular tachycardia
1.4
6.5
304
2206
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
3.9
6.4
24
61
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
2.5
6.4
46
183
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
4.5
6.4
21
47
M02AA07
ATC
piroxicam; topical
1.1
6.4
3430
31693
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
2.4
6.4
52
219
TQB05
NOMESCO Finland
Puncture of skin of trunk
2.2
6.4
61
280
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.3
6.4
552
4374
J02AC01
ATC
fluconazole; systemic
1.1
6.4
3028
27781
4019X
ICD-9 Finland
Essential hypertension, Unspecified
1.4
6.4
287
2062
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.3
6.4
523
4121
GA5AA
NOMESCO Finland
Rib X-ray examination
2.9
6.4
37
129
R4130
NOMESCO Finland
Speech therapy
1.6
6.4
152
953
WX720
NOMESCO Finland
Own respiration
1.4
6.4
263
1863
D99
ICPC
Disease digestive system other
2.0
6.4
73
363
U04
ICPC
Incontinence urine
1.3
6.4
374
2809
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.3
6.4
561
4461
JF1BD
NOMESCO Finland
Very extensive small bowel CT
2.4
6.4
49
203
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
1.8
6.4
94
514
B02.9
ICD-10 Finland
Zoster without complication
1.3
6.4
431
3308
F32.1
ICD-10 Finland
Moderate depressive episode
1.4
6.4
264
1873
C08CA02
ATC
felodipine; oral
1.2
6.4
873
7296
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.2
6.4
801
6634
T83
ICPC
Overweight
1.8
6.4
101
563
GAA31
NOMESCO Finland
Thoracoscopy
3.0
6.4
34
115
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
3.0
6.4
34
115
JFH10
NOMESCO Finland
Total colectomy and ileostomy
3.9
6.3
24
62
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
1.6
6.3
158
1004
JLC10
NOMESCO Finland
Distal pancreatectomy
3.2
6.3
30
93
K02.9
ICD-10 Finland
Dental caries, unspecified
1.8
6.3
103
580
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
2.6
6.3
42
161
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
1.5
6.3
174
1134
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.5
6.3
207
1398
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
1.7
6.3
133
807
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
1.8
6.3
99
550
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
2.5
6.3
46
186
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
6.3
201
1350
J01DC02
ATC
cefuroxime; systemic
1.3
6.3
369
2771
N07BB01
ATC
disulfiram; oral
1.4
6.3
266
1891
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
1.5
6.3
204
1378
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.8
6.3
859
10154
SPAT1127
SPAT
Enema
2.0
6.3
77
394
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
1.4
6.3
326
2405
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
2.9
6.3
34
116
N06AG02
ATC
moclobemide; oral
1.4
6.3
319
2342
N05AA01
ATC
chlorpromazine; systemic, rectal
1.8
6.3
93
509
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
4.0
6.3
23
58
NG2AA
NOMESCO Finland
Patella X-ray examination
1.5
6.3
191
1271
O88.2
ICD-10 Finland
Obstetric blood-clot embolism
+∞
6.2
6
*
6BA02
NOMESCO Finland
NA
3.8
6.2
24
63
U01
ICPC
Dysuria/painful urination
1.3
6.2
501
3941
L29.9
ICD-10 Finland
Pruritus, unspecified
1.6
6.2
163
1046
N05BE01
ATC
buspirone; oral
1.5
6.2
194
1299
N20.9
ICD-10 Finland
Urinary calculus, unspecified
1.5
6.2
174
1136
J15.8
ICD-10 Finland
Other bacterial pneumonia
2.1
6.2
62
291
SPAT1210
SPAT
Application of cast or individual aid
1.4
6.2
291
2108
TQW80
NOMESCO Finland
Local dermatologic skincare
1.5
6.2
185
1228
AE1
HP
Pulmonary artery thrombendarterectomy
26.7
6.2
8
*
V03AE01
ATC
polystyrene sulfonate; oral
1.8
6.2
102
577
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.1
6.2
64
303
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
2.9
6.2
34
117
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
4.3
6.2
21
49
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
1.7
6.2
118
697
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.0
6.2
72
362
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
2.6
6.2
41
157
AA400
NOMESCO Finland
Electroconvulsive therapy
2.3
6.2
54
239
L04AA01
ATC
[U] ciclosporin; systemic
1.8
6.2
107
613
R60.1
ICD-10 Finland
Generalized oedema
2.4
6.2
49
208
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
2.1
6.2
67
327
P80
ICPC
Personality disorder
3.2
6.2
30
95
ECB00
NOMESCO Finland
Suture of gingiva
1.4
6.2
253
1792
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
3.4
6.2
27
79
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
2.1
6.2
62
293
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
1.4
6.2
267
1911
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
4.1
6.2
22
54
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
2.2
6.2
57
260
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
2.2
6.2
59
272
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
2.5
6.2
44
175
GD6AD
NOMESCO Finland
CT of chest and neck
3.2
6.1
29
90
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
1.7
6.1
126
759
I82.0
ICD-10 Finland
Budd-Chiari syndrome
6.3
6.1
15
24
AA1AA
NOMESCO Finland
Head X-ray examination
2.1
6.1
66
319
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.2
6.1
913
7690
SPAT1076
SPAT
Cannulation of central vein
5.3
6.1
17
32
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.8
6.1
90
493
J98.6
ICD-10 Finland
Disorders of diaphragm
2.6
6.1
41
159
321
Kela drug reimbursment
Paricalcitol and cinacalcet
2.4
6.1
50
213
NAK30
NOMESCO Finland
Osteotomy of spine
7.6
6.1
13
17
ZXE90
NOMESCO Finland
More than 22 hours
2.0
6.1
71
357
G57.1
ICD-10 Finland
Meralgia paraesthetica
1.8
6.1
95
527
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
2.4
6.1
48
203
A05
ICPC
Feeling ill
1.4
6.1
311
2290
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
3.5
6.1
26
75
A60
ICPC
General and Unspecified, Result test/procedure
1.4
6.1
312
2301
K60
ICPC
Cardiovascular, Result test/procedure
1.9
6.1
75
386
SPAT1279
SPAT
Preparation of immediate hospitalisation
1.8
6.1
97
546
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
3.8
6.0
23
60
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
2.1
6.0
63
301
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
3.7
6.0
24
65
WX290
NOMESCO Finland
Other blockade of nerve
1.1
6.0
3082
28388
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.4
6.0
276
1993
C10AA05
ATC
atorvastatin; oral
1.1
6.0
3650
33929
K22
ICPC
Risk factor cardiovascular disease
1.3
6.0
402
3082
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
2.7
6.0
37
137
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
2.7
6.0
37
137
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
4.4
6.0
20
46
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
1.8
6.0
93
518
B80
ICPC
Iron deficiency anaemia
1.6
6.0
130
798
A10BJ02
ATC
liraglutide; parenteral
1.6
6.0
151
961
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
3.3
6.0
27
81
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018677) aPTT in Platelet poor plasma by Coagulation assay
3316
17079
2.26
321.77
3.6
2.0
s
30.9
30.0
8.37
3228
16558
(42870588) Differential panel, method unspecified - Blood
5639
35551
2.03
321.44
7.6
5.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2679
12675
2.40
316.46
2.2
1.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
7053
48270
2.00
316.40
8.5
6.2
%
8.7
8.8
0.19
6719
44727
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2677
12669
2.40
315.97
2.1
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
7021
48009
1.99
315.37
8.2
5.8
%
2.6
2.9
14.41
6681
44299
(3001604) Monocytes [#/volume] in Blood
7351
51129
1.99
313.71
7.7
5.6
e9/l
0.6
0.6
4.45
6397
43630
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
6453
42982
1.99
311.25
5.4
3.9
ng/l
64.4
77.3
0.18
5100
31324
(3006315) Basophils [#/volume] in Blood
7368
51423
1.99
309.74
7.8
5.6
e9/l
0.0
0.0
0.05
6417
43897
(3012095) Magnesium [Moles/volume] in Serum or Plasma
3630
17616
2.47
307.65
4.8
3.1
mmol/l
0.8
0.8
8.23
3447
16289
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
6277
34427
2.58
307.65
3.8
3.1
ng/l
1401.7
1688.3
6.18
5624
29613
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
419
284
15.20
307.65
1.1
1.1
%
100.3
94.0
2.09
350
213
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
1390
927
16.65
307.65
1.1
1.1
%
119.2
117.3
0.79
1268
827
(3022217) INR in Platelet poor plasma by Coagulation assay
3301
15912
2.43
307.65
37.6
27.2
inr
1.6
1.4
6.27
322
2198
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
2296
3623
7.47
307.65
3.9
2.8
u/ml
0.4
0.3
4.80
1541
1982
(3033658) Prothrombin time (PT) actual/Normal
4759
26859
2.21
307.65
5.9
3.9
%
84.8
87.5
9.05
4601
26192
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
3093
12868
2.84
307.65
8.6
6.7
kpa
5.0
5.1
0.96
2942
12205
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
1029
694
16.00
307.65
1.2
1.1
%
94.7
96.5
0.78
962
650
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
475
410
11.98
307.65
1.2
1.1
ratio
1.1
1.1
1.25
162
146
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
2031
2437
9.67
307.65
2.7
2.1
%
95.5
89.2
20.68
1844
2295
(3036489) Thrombin time
2093
3216
7.55
307.65
2.6
1.9
s
21.7
21.5
0.61
1686
2883
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
3731
18411
2.43
307.65
2.3
1.8
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1252
2575
5.27
307.65
3.6
2.4
g/l
3.7
3.6
1.36
1198
2436
(4306422)
1422
953
16.61
307.65
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
7785
45782
2.72
307.65
15.9
9.6
inr
1.5
1.3
2.01
2302
12633
(3022096) Basophils/100 leukocytes in Blood
6901
46604
2.01
307.65
8.1
5.9
%
0.6
0.7
9.71
6567
43035
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
7955
55260
2.12
307.65
10.3
6.5
mmol/l
1.2
1.2
16.94
6680
46232
(3013650) Neutrophils [#/volume] in Blood by Automated count
8281
59565
2.06
307.65
14.7
8.6
e9/l
4.4
4.2
8.63
7397
51536
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
7460
50011
2.14
307.65
9.3
5.8
mmol/l
1.2
1.2
24.24
6957
44810
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
1672
2291
8.22
307.65
3.0
2.4
%
205.4
196.1
3.02
1575
2178
(4268621)
848
704
12.80
307.65
2.5
2.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
2425
10513
2.60
307.65
9.9
7.5
g/l
121.8
120.4
2.61
2353
10125
(3003396) Base excess in Arterial blood by calculation
3072
12851
2.81
307.65
8.6
6.7
mmol/l
1.3
1.1
2.26
2451
9996
(3023368) Bacteria identified in Blood by Culture
5837
31060
2.58
307.65
6.0
4.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1971
7504
2.91
307.65
5.6
4.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
5885
21863
4.07
307.65
2.7
1.7
mg/l
2.3
1.2
51.04
4873
16810
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
1224
1036
12.92
307.65
1.3
1.2
u/ml
3.7
4.1
0.43
537
472
(3027801) Oxygen [Partial pressure] in Arterial blood
3091
12865
2.83
307.65
8.6
6.7
kpa
11.1
12.2
27.11
2928
12189
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
8111
55975
2.17
307.65
10.6
5.9
umol/l
11.0
11.8
8.44
7828
52839
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
494
378
13.54
307.65
1.3
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
2748
11488
2.76
307.65
9.0
7.1
%
94.7
95.6
7.73
2656
11021
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
1293
1050
13.55
307.65
1.3
1.2
u/ml
4.0
3.7
0.08
394
370
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
1367
967
15.66
307.65
1.1
1.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
7133
49352
1.97
306.12
8.3
6.0
%
25.0
26.9
36.55
6782
45449
(3019198) Lymphocytes [#/volume] in Blood
7460
52528
1.97
302.79
7.8
5.7
e9/l
1.8
1.9
2.54
6601
45621
(3013115) Eosinophils [#/volume] in Blood
7505
53037
1.97
300.39
8.2
5.8
e9/l
0.2
0.2
7.59
6618
45949
(3034426) Prothrombin time (PT)
297
247
12.28
297.44
1.2
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
8529
63376
1.99
289.97
8.0
4.7
mmol/l
6.8
6.8
0.18
8227
59371
(3018010) Neutrophils/100 leukocytes in Blood
6983
48619
1.93
286.85
7.9
5.8
%
59.7
58.0
24.30
6645
44970
(3024561) Albumin [Mass/volume] in Serum or Plasma
6901
47923
1.93
285.04
7.3
4.6
g/l
33.3
35.0
110.37
6495
44068
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
3828
21921
2.05
275.83
5.1
3.9
ng/l
232.4
479.0
3.23
3232
17967
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1603
6402
2.71
267.35
8.5
6.6
mmol/l
24.8
24.8
0.12
1588
6336
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2596
12932
2.26
267.12
4.8
4.0
u/l
257.7
245.3
3.23
2486
12106
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1677
7096
2.56
247.77
8.6
6.8
mmol/l
24.8
24.6
1.37
1581
6611
(3018418) pH of Serum or Plasma
5055
32784
1.88
246.60
5.7
4.0
ph
7.4
7.4
1.66
1238
6135
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2737
14369
2.14
244.57
6.6
5.5
mmol/l
1.0
1.0
0.03
2551
13233
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1458
5852
2.68
239.49
10.5
8.5
mmol/l
24.6
24.3
2.18
1334
5410
(3020779) Urea [Moles/volume] in Serum or Plasma
2097
9968
2.31
238.88
8.2
6.8
mmol/l
10.0
10.7
4.03
1977
9415
(3014576) Chloride [Moles/volume] in Serum or Plasma
2679
14108
2.13
236.59
9.7
6.6
mmol/l
104.5
104.4
0.24
2593
13814
(3014111) Lactate [Moles/volume] in Serum or Plasma
2064
9820
2.31
234.27
9.0
6.4
mmol/l
1.4
1.4
0.77
1969
9408
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
297
351
8.63
231.43
1.2
1.1
u/ml
33.4
13.4
0.47
22
34
(3022948) Iron [Moles/volume] in Serum or Plasma
3124
17587
2.02
229.34
2.9
2.5
umol/l
11.3
12.5
17.04
2927
16104
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2815
15282
2.07
228.33
3.0
2.6
%
20.0
21.9
11.36
2442
12833
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2935
16291
2.03
223.37
2.9
2.5
g/l
2.3
2.3
1.31
2750
14928
(3042936) Bacteria identified in Isolate by Culture
2787
15234
2.05
221.01
2.3
2.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2336
11953
2.16
220.63
5.3
3.9
ug/l
34.1
22.1
1.34
1971
9814
(3027315) Oxygen [Partial pressure] in Blood
825
2545
3.39
215.77
5.3
4.0
kpa
8.4
8.5
1.31
808
2477
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
248
257
9.81
213.69
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
1925
9253
2.27
211.60
10.4
7.7
—
—
—
0
0
(3010421) pH of Blood
891
2918
3.20
211.30
5.2
4.0
ph
7.4
7.4
0.73
787
2473
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
1196
4626
2.74
210.16
2.4
1.9
ug/l
2.9
2.4
0.14
1055
4021
(3014007) Fractional oxyhemoglobin in Arterial blood
1572
6980
2.42
207.32
11.2
8.4
%
93.0
93.9
6.14
1565
6953
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1519
6648
2.45
206.78
4.6
3.4
mmol/l
2.2
1.8
2.86
1171
4910
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
799
2484
3.36
206.23
1.9
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
1553
6896
2.42
204.65
4.7
3.5
ph
7.4
7.4
0.58
276
865
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1755
8223
2.31
204.53
1.9
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1565
6988
2.41
203.64
4.7
3.5
kpa
5.2
5.2
0.24
1464
6392
(3013290) Carbon dioxide [Partial pressure] in Blood
805
2538
3.31
203.07
5.3
4.0
kpa
5.0
5.0
0.09
788
2471
(3012501) Base excess in Blood by calculation
804
2537
3.31
202.53
5.3
4.0
mmol/l
2.7
2.6
0.18
594
1713
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1559
6966
2.40
202.48
11.2
8.4
%
0.7
0.7
0.12
1551
6915
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1556
6979
2.39
200.26
11.2
8.3
%
1.4
1.4
0.39
1547
6929
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
766
2386
3.35
196.94
1.9
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1381
5948
2.48
194.07
12.3
9.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4946
33640
1.75
193.35
3.4
2.5
u/l
53.3
59.1
8.02
4660
30847
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
9882
81653
1.85
192.02
13.3
7.4
u/l
84.2
79.6
13.52
9533
76354
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
2014
10249
2.14
190.48
3.5
3.0
ng/l
186.0
232.9
5.48
1840
9336
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
219
238
9.34
182.08
1.2
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
5563
39708
1.70
178.27
4.5
3.4
—
0.5
—
0
5
(40767503) Oxygen content in Capillary blood by calculation
732
2382
3.19
174.83
3.0
2.5
%
16.1
16.0
0.08
358
1234
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1446
6667
2.31
173.38
1.7
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
4859
33673
1.70
172.19
4.4
3.3
e6/l
110.8
98.5
0.22
3890
25959
(3021447) Carbon dioxide [Partial pressure] in Venous blood
2005
10573
2.06
171.02
4.5
3.7
kpa
5.9
5.8
2.37
1933
10249
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
4235
28315
1.73
170.81
2.7
2.3
mg/l
3.5
3.0
17.22
3713
23936
(3002032) Base excess in Venous blood by calculation
1998
10543
2.06
170.04
4.6
3.7
mmol/l
2.2
1.9
3.41
1654
8550
(1616796) Gas panel - Central venous blood
741
2484
3.10
168.17
4.4
3.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
4863
33883
1.69
167.73
3.2
2.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
4949
34662
1.69
167.24
4.1
3.3
—
—
—
0
0
(3012544) pH of Venous blood
2043
10963
2.02
165.62
4.5
3.7
ph
7.4
7.4
0.08
15
56
(3028271) Lactate [Moles/volume] in Capillary blood
587
1769
3.43
158.59
2.2
1.8
mmol/l
1.7
1.7
0.69
579
1729
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4654
32450
1.67
157.51
4.7
3.1
u/l
35.1
35.0
0.05
4408
30522
(3022806) Fractional oxyhemoglobin in Capillary blood
509
1404
3.73
157.26
2.1
1.8
%
89.2
89.3
0.07
504
1384
(3030467) Casts [#/volume] in Urine by Automated count
4476
30910
1.68
157.07
4.2
3.2
e6/l
0.6
0.5
1.62
3540
23430
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6461
48964
1.63
156.76
5.3
4.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
590
1807
3.37
155.34
1.7
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
588
1800
3.37
154.93
2.0
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
4312
29761
1.67
150.01
4.2
3.2
—
—
—
0
0
(3026782) Osmolality of Urine
3420
22194
1.73
149.72
3.8
2.8
mosm/kgh2o
534.1
545.9
2.58
3016
18846
(3018095) Leukocytes [#/volume] in Urine
5310
38671
1.63
148.95
5.1
3.8
e6/l
129.9
109.2
0.64
4046
27807
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1413
6856
2.19
148.54
2.0
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1799
9710
1.99
141.72
2.9
2.5
g/l
64.8
66.3
11.47
1657
8648
(40758558) Short blood count panel - Blood
3864
26323
1.66
139.13
10.9
6.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
8559
70632
1.61
136.91
6.4
4.8
e6/l
1462.7
1714.5
0.18
162
1059
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
519
1590
3.36
136.41
1.6
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
2257
13281
1.84
136.29
3.1
2.3
%
2.0
1.8
15.87
2005
11574
(3015377) Calcium [Moles/volume] in Serum or Plasma
5081
37175
1.60
136.19
5.3
3.3
mmol/l
2.3
2.4
4.45
4499
31833
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
479
1399
3.51
135.68
1.6
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
2097
12084
1.87
135.24
3.4
2.6
umol/l
9.4
8.9
0.39
1804
10468
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1828
10109
1.94
133.56
2.5
2.1
g/l
0.2
0.2
1.72
1692
9330
(3018405) Lactate [Moles/volume] in Arterial blood
936
3996
2.44
132.27
4.7
4.0
mmol/l
1.4
1.4
0.22
920
3928
(3021589) Normoblasts [#/volume] in Blood
5881
45012
1.55
126.56
15.8
9.9
e9/l
0.0
0.0
0.76
4783
36704
(3000850) Epithelial cells [#/volume] in Urine
3491
23644
1.65
126.23
3.5
2.6
e6/l
5.7
5.3
0.97
3134
20624
(3028626) Oxygen [Partial pressure] in Capillary blood
658
2432
2.79
124.61
3.5
2.8
kpa
8.1
7.9
0.93
620
2240
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
659
2443
2.79
124.09
1.6
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
917
3992
2.39
123.88
4.2
3.3
u/ml
2925.3
1767.7
0.40
775
3410
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
470
1449
3.33
122.19
1.7
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
897
3920
2.38
120.04
3.0
2.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
1059
4992
2.22
118.50
5.0
3.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1627
8992
1.92
118.07
2.8
2.1
nmol/l
363.6
377.9
1.65
1524
8180
(4035726)
1677
9369
1.91
117.75
1.5
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
462
1447
3.27
117.04
1.8
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1584
8708
1.93
116.71
4.0
3.1
kpa
4.6
4.5
0.59
1524
8405
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
3700
25831
1.60
116.46
3.1
2.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
2090
12590
1.78
114.87
2.1
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
713
2858
2.58
114.86
3.8
3.0
mmol/l
25.0
24.8
0.32
644
2495
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
542
1895
2.94
113.64
7.8
5.0
iu/ml
579.2
2098.0
0.94
104
280
(3017181) Myelocytes/100 leukocytes in Blood
1593
8889
1.90
111.89
4.6
4.0
%
1.0
0.9
0.64
663
2540
(3021901) Oxygen saturation in Capillary blood
570
2073
2.83
111.13
3.3
2.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1079
5253
2.15
111.09
4.4
3.9
mmol/l
24.3
24.1
1.06
974
4690
(3009445) Proteinase 3 Ab [Units/volume] in Serum
971
4535
2.23
110.92
1.8
1.5
u/ml
19.1
17.0
0.12
34
114
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
397
1175
3.45
110.05
1.9
1.5
—
—
—
0
0
(3020891) Body temperature
964
4516
2.22
109.26
5.9
4.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
146
185
7.97
107.37
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1704
9863
1.84
106.27
2.9
2.4
u/l
47.9
50.7
0.07
1463
8394
(3001122) Ferritin [Mass/volume] in Serum or Plasma
5491
42505
1.50
105.39
3.6
2.8
ug/l
185.3
143.8
6.76
5107
38691
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
747
3191
2.42
104.88
1.8
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
1712
9964
1.83
104.76
3.1
2.4
e9/l
75.8
68.4
11.83
1252
7578
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
764
3395
2.33
97.96
1.4
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
769
3432
2.32
97.61
5.2
4.2
mmol/l
3.9
3.9
0.04
705
3230
(3005719) IgG [Mass/volume] in Serum or Plasma
1339
7376
1.91
97.04
3.7
2.7
g/l
10.1
10.7
3.96
1260
6719
(3047181) Lactate [Moles/volume] in Blood
771
3461
2.30
96.52
8.4
5.9
mmol/l
1.3
1.3
0.99
681
3051
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
967
4756
2.11
96.52
6.9
5.0
%
1.7
1.6
0.69
899
4457
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2645
17718
1.62
95.80
3.7
3.0
e6/l
2.9
2.5
1.12
1472
9705
(40760892) CBC W Ordered Manual Differential panel - Blood
3092
21497
1.57
95.65
6.0
4.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
4517
34075
1.50
95.65
2.7
2.1
u/l
226.8
217.7
0.22
4263
31750
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1873
11502
1.73
94.62
5.2
3.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
1420
8069
1.85
93.21
4.4
3.8
%
0.8
0.7
0.61
472
1829
(3037467) Urinalysis macro (dipstick) panel - Urine
8496
72678
1.48
93.19
6.2
4.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
948
4692
2.10
92.96
7.0
5.0
%
0.9
0.9
0.66
888
4398
(3021440) Promyelocytes/100 leukocytes in Blood
1472
8474
1.83
92.61
4.7
4.0
%
0.1
0.1
0.01
612
2369
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
886
4285
2.14
92.26
5.4
3.7
mmol/l
25.2
24.9
2.50
829
3868
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
564
2265
2.56
90.22
4.2
3.2
u/ml
2090.5
428.0
1.74
508
2071
(44806118)
348
1083
3.27
89.00
1.8
1.4
—
—
—
0
0
(44790048)
348
1083
3.27
89.00
1.8
1.4
—
—
—
0
0
(44790049)
348
1083
3.27
89.00
1.8
1.4
—
—
—
0
0
(44790047)
348
1083
3.27
89.00
1.8
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1036
5442
1.98
86.00
2.1
1.6
g/l
1.7
1.6
4.90
891
4623
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
413
1449
2.91
85.90
3.3
2.4
u/ml
13799.7
1673.9
0.44
40
83
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
279
784
3.61
83.70
1.9
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
631
2781
2.33
82.24
1.8
1.6
g/l
0.2
0.2
3.37
595
2612
(3004588) Protein electrophoresis panel - Serum or Plasma
1385
8105
1.79
81.96
2.8
2.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2974
21147
1.52
80.93
4.9
3.0
mmol/l
2.5
2.5
15.63
2641
18278
(3039000) Anion gap in Blood
580
2482
2.40
80.81
9.2
6.8
mmol/l
11.1
11.2
0.35
524
2218
(3018572) Chloride [Moles/volume] in Blood
580
2483
2.40
80.74
9.2
6.8
mmol/l
105.4
105.0
1.39
524
2219
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
643
2880
2.30
80.68
1.9
1.6
g/l
1.2
1.2
4.78
607
2713
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1533
9292
1.74
80.19
6.1
3.8
mmol/l
1.2
1.2
2.63
1429
8013
(3023183) Ammonium ion [Moles/volume] in Plasma
526
2161
2.49
80.12
2.5
2.6
umol/l
32.1
34.0
0.94
437
1800
(46235355) HIV 1 and 2 tests - Meaningful Use set
1920
12391
1.64
79.22
1.7
1.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
743
3558
2.15
79.10
1.9
1.6
titre
247.2
251.3
0.02
46
151
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
239
630
3.84
78.71
1.4
1.5
umol/l
13.4
13.2
0.13
224
592
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
808
4004
2.08
78.64
2.7
2.2
ug/l
566.6
626.2
0.15
765
3768
(3025159) Blasts/100 leukocytes in Blood
1350
7945
1.78
78.17
4.7
4.0
%
0.1
0.3
1.37
515
1999
(3023419) Bacteria identified in Sputum by Culture
386
1375
2.86
78.06
2.8
2.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
437
1663
2.68
77.89
1.4
1.5
g/l
34.5
31.6
4.91
399
1468
(3028026) IgM [Mass/volume] in Serum or Plasma
1058
5782
1.90
77.83
2.3
1.8
g/l
1.2
1.4
2.04
991
5192
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
399
1450
2.81
77.73
7.1
6.4
mg/l
11.7
11.9
0.56
365
1313
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
292
888
3.34
77.52
1.8
1.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
1211
6929
1.82
77.00
4.5
3.3
g/l
125.5
127.8
2.72
1181
6761
(3026493) Urate [Moles/volume] in Serum or Plasma
3779
28453
1.46
76.72
3.6
2.7
umol/l
4010.5
5358.7
1.31
3267
24205
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1672
10497
1.68
76.59
2.6
2.4
ug/l
7.5
7.0
0.25
1415
8950
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2709
19083
1.53
76.37
3.5
2.8
e6/l
1.4
1.3
0.19
1535
10985
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
577
2543
2.33
75.12
1.5
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1504
9231
1.71
74.86
1.6
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
576
2543
2.32
74.69
1.5
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
394
1481
2.71
71.93
1.4
1.5
e6/l
2200.3
2799.0
0.51
284
1065
(3027273) Bicarbonate [Moles/volume] in Venous blood
1016
5627
1.87
71.51
4.5
3.4
mmol/l
25.5
25.2
1.51
978
5469
(44806071)
85
92
9.29
70.88
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
569
2561
2.28
70.47
2.6
2.2
g/l
128.3
127.5
0.27
437
1844
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
621
2905
2.19
70.01
1.8
1.4
iu/ml
14.3
16.1
0.14
24
56
(3013707) Erythrocyte sedimentation rate by Westergren method
8741
76900
1.41
69.82
5.6
4.1
mm/h
16.8
13.4
54.51
8174
70480
(3004809) Band form neutrophils/100 leukocytes in Blood
448
1823
2.51
69.59
3.3
3.5
%
1.5
1.5
0.01
357
1394
(3019174) dRVVT (LA screen)
71
63
11.32
68.06
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
323
1135
2.89
66.98
1.5
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
350
1284
2.77
66.97
1.5
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
373
1423
2.67
66.14
1.2
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1901
12754
1.57
65.66
1.4
1.3
titre
597.9
529.7
0.75
405
2739
(3042631) Mycobacterium sp identified in Specimen
402
1606
2.55
64.90
2.6
2.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
301
1036
2.95
64.81
1.9
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
356
1343
2.70
64.54
1.5
1.5
e6/l
56991.7
63598.2
0.16
214
798
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
217
618
3.55
63.85
1.9
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
234
703
3.37
63.38
1.9
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
310
1100
2.86
63.15
1.4
1.4
mmol/l
5.8
6.4
3.26
285
1003
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
285
972
2.97
62.38
1.9
1.7
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
214
615
3.52
62.11
1.9
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
270
898
3.05
61.77
1.8
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
270
898
3.05
61.77
1.8
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
270
898
3.05
61.77
1.8
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
863
4751
1.87
61.63
2.5
2.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
364
1422
2.60
61.54
1.9
1.8
ug/l
22.6
23.3
0.08
359
1381
(3044009) aPTT.lupus sensitive (LA screen)
67
65
10.35
60.47
1.2
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1623
10693
1.59
60.20
1.6
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
923
5233
1.82
59.94
5.2
4.0
%
50.0
47.4
2.65
912
5174
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
921
5258
1.81
58.42
3.8
2.7
%
0.7
0.7
0.39
900
5031
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
853
4777
1.84
57.60
5.8
3.6
u/ml
118.3
72.8
1.45
826
4581
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
780
4254
1.89
57.27
2.5
2.2
g/l
10.1
10.2
0.39
657
3507
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
793
4348
1.88
57.26
2.2
1.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
821
4562
1.85
56.83
2.5
2.2
g/l
7.5
7.5
0.31
618
3325
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
820
4556
1.85
56.78
2.5
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
818
4548
1.85
56.51
2.5
2.2
g/l
3.9
3.8
1.14
596
3184
(40768806) Pleura Pathology biopsy report
332
1298
2.60
56.05
1.5
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
718
3845
1.92
55.71
2.8
2.4
g/l
0.9
1.0
0.22
616
3234
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
643
3345
1.97
54.34
2.5
2.2
g/l
0.0
0.0
0.20
588
3012
(3019977) pH of Arterial blood
206
632
3.29
54.00
2.3
2.7
ph
7.4
7.4
0.87
75
234
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
767
4247
1.86
53.63
2.5
2.3
g/l
3.2
3.1
1.84
610
3245
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
604
3126
1.98
51.78
2.5
2.3
g/l
0.0
0.0
1.04
550
2803
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
595
3074
1.98
51.26
2.5
2.3
g/l
0.0
0.0
0.00
550
2791
(3011412) CD3 cells [#/volume] in Blood
250
886
2.86
51.09
2.3
2.3
e9/l
1.2
1.1
0.15
174
543
(40761536) Microorganisms panel - Urine sediment
1344
8799
1.59
50.68
5.8
4.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
455
2153
2.15
49.72
1.6
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
654
3529
1.90
49.51
2.4
2.2
g/l
36.3
37.4
4.24
566
2965
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
204
657
3.14
49.38
2.0
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
386
1727
2.27
48.43
1.5
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
903
5403
1.72
48.43
1.4
1.3
u/ml
195.0
243.0
0.89
833
4952
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
681
3757
1.86
48.09
4.0
3.1
ratio
1.4
3.2
2.11
40
287
(3035350) Ketones [Presence] in Urine by Test strip
5997
51328
1.31
47.94
5.1
3.9
estimate
0.0
0.0
1.08
1431
9294
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
352
1536
2.33
46.84
1.5
1.4
u/ml
108.4
121.5
1.28
89
332
(3021601) Nitrite [Presence] in Urine by Test strip
5993
51407
1.30
46.63
6.8
5.2
estimate
0.0
0.0
0.80
1430
9404
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
691
3866
1.83
46.63
4.0
3.1
mg/l
56.2
47.6
0.19
530
3134
(3034860) Kappa light chains.free [Mass/volume] in Serum
690
3869
1.83
46.22
4.0
3.1
mg/l
65.2
72.6
0.17
531
3134
(3000494) Fungus identified in Specimen by Culture
1701
11943
1.49
46.20
1.8
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
6047
52023
1.30
45.65
5.2
3.9
estimate
0.0
0.0
0.05
1402
9208
(3037692) Legionella sp identified in Specimen by Organism specific culture
136
355
3.86
45.56
1.5
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
366
1651
2.25
45.04
1.8
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
724
4158
1.78
44.77
1.8
1.9
u/l
38.2
38.9
0.41
639
3591
(3035637) Corticotropin [Mass/volume] in Plasma
287
1168
2.49
44.61
1.6
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
275
1098
2.54
44.50
3.7
3.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
201
685
2.96
44.15
2.0
1.9
%
13.5
15.0
0.53
87
273
(1175426) CD3 cells/100 lymphocytes in Blood
203
702
2.92
43.44
2.0
2.0
%
73.4
71.8
0.61
196
664
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
515
2683
1.96
43.27
1.7
1.6
—
—
—
0
0
(3013512) EKG study
3981
32571
1.32
42.73
5.2
4.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
198
685
2.92
42.35
1.3
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
886
5463
1.67
42.33
1.3
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
170
539
3.18
42.31
2.1
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
170
539
3.18
42.31
2.1
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
170
539
3.18
42.31
2.1
1.8
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
154
460
3.37
42.22
1.7
2.2
%
100.8
95.4
0.89
139
431
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
170
540
3.18
42.18
2.1
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1281
8633
1.54
42.09
4.1
3.6
ng/l
102.6
93.4
2.37
1099
7289
(3019309) Folate [Moles/volume] in Red Blood Cells
2946
23115
1.35
41.99
2.0
1.8
nmol/l
1191.9
1165.0
0.79
2268
17144
(40759836) Histone Ab [Presence] in Serum by Immunoblot
191
652
2.96
41.85
1.2
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
169
538
3.17
41.78
2.1
2.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
191
653
2.95
41.74
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
191
653
2.95
41.74
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
191
658
2.93
41.18
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
191
658
2.93
41.18
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
191
659
2.93
41.07
1.2
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5085
43162
1.29
40.97
2.6
2.2
nmol/l
76.8
78.7
4.29
4548
38045
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
336
1522
2.24
40.95
1.3
1.2
u/ml
299.0
282.8
0.43
225
940
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
224
845
2.68
40.71
1.4
1.4
u/l
11.5
13.2
3.63
216
808
(3024980) IgG subclass 4 [Mass/volume] in Serum
335
1520
2.23
40.67
1.6
1.6
g/l
0.8
0.8
0.05
261
1130
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
272
1128
2.44
40.62
1.3
1.3
u/l
420.4
408.5
0.07
257
1063
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
10895
102270
1.38
40.45
31.4
15.6
mg/l
28.8
25.4
22.72
10123
82502
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
143
419
3.44
40.42
2.3
2.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
228
871
2.65
40.42
1.3
1.3
u/l
11.5
13.5
1.19
210
796
(3052851) Hemolysis interference index of Serum or Plasma
612
3446
1.81
40.39
4.1
3.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
277
1169
2.40
39.81
4.5
3.9
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
210
779
2.72
39.45
2.0
2.1
%
37.4
42.0
0.38
16
93
(3015736) pH of Urine
4766
40265
1.29
39.34
4.6
3.6
ph
5.6
5.7
—
7
33
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
349
1632
2.17
39.33
1.3
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
140
414
3.41
39.02
2.3
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
140
414
3.41
39.02
2.3
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
7205
64151
1.27
38.51
4.2
3.1
u/l
65.9
51.6
17.87
6743
58814
(3044242) Glucose [Moles/volume] in Arterial blood
165
545
3.05
38.35
1.7
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
3315
26797
1.32
37.81
1.8
1.6
nmol/l
19.2
20.3
4.21
2907
22741
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
497
2683
1.89
37.51
3.4
2.7
mg/l
1.8
1.6
3.86
460
2409
(3021879) Hepatitis B virus core Ab [Presence] in Serum
932
5993
1.60
37.49
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
435
2247
1.97
37.47
1.3
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
237
960
2.49
37.27
1.4
1.4
g/l
6.7
7.0
0.46
177
657
(40760888) Immunoglobulin light chains.free panel - Serum
529
2920
1.85
37.23
4.2
3.2
—
—
—
0
0
(3044889) 12 lead EKG panel
8124
73570
1.27
36.96
5.1
4.0
—
—
—
0
0
(4010399)
1119
7541
1.53
36.56
1.5
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
235
960
2.47
36.30
1.4
1.4
g/l
0.4
0.4
1.79
174
661
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
411
2111
1.98
35.99
1.5
1.2
titre
228.0
135.5
0.23
15
44
(3037121) Protein [Mass/volume] in Urine
637
3752
1.73
35.98
4.3
2.9
g/l
0.3
0.3
0.87
350
1521
(4062490)
235
966
2.46
35.82
1.4
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
234
961
2.46
35.74
1.4
1.4
g/l
2.8
2.9
0.42
173
664
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
71
134
5.32
35.71
1.5
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
259
1122
2.33
35.12
3.4
3.5
%
61.2
58.7
0.89
180
709
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
251
1074
2.36
35.01
3.2
2.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
6257
55318
1.25
33.31
3.0
2.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
3409
28051
1.29
33.20
5.7
4.3
estimate
0.0
0.0
0.25
1350
8988
(3007164) IgA [Mass/volume] in Serum or Plasma
2263
17690
1.34
31.84
1.8
1.5
g/l
2.6
2.6
0.02
1476
10331
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
254
1142
2.25
31.60
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
175
665
2.65
31.45
1.3
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
299
1439
2.10
31.35
1.1
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
110
322
3.44
31.24
2.4
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
110
322
3.44
31.24
2.4
2.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
3266
26902
1.28
31.18
5.0
3.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
56
99
5.67
30.25
1.2
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
78
185
4.23
29.89
2.7
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
420
2315
1.84
29.71
3.9
3.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
220
956
2.32
29.69
1.7
1.4
iu/ml
54.6
22.3
0.85
14
43
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
111
339
3.29
29.51
1.8
1.9
u/ml
2726.6
58709.9
1.01
24
44
(3004451) EKG impression Narrative
153
566
2.72
29.02
1.3
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
147
533
2.78
28.97
2.4
2.7
%
38.1
37.6
0.07
57
180
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
158
596
2.67
28.85
2.4
2.4
e6/l
782.3
513.6
0.60
133
496
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
153
569
2.71
28.73
2.5
2.5
e9/l
0.2
0.2
0.63
136
494
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
59
115
5.15
28.68
2.1
2.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
100
293
3.43
28.40
1.2
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
283
1386
2.06
28.36
2.4
2.6
u/ml
187.0
1247.3
0.88
276
1351
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
457
2623
1.77
28.27
1.8
1.9
mg/l
11.2
11.7
0.48
420
2417
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
91
252
3.63
28.15
1.0
1.1
%
90.5
86.3
0.47
46
125
(3034770) Mitochondria Ab [Titer] in Serum
452
2598
1.77
27.83
1.2
1.2
titre
1298.0
862.2
—
5
85
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
115
374
3.09
27.58
1.6
2.0
%
189.0
155.7
2.92
106
351
(3000492) Spirometry study
1222
8854
1.42
27.25
1.6
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
268
1306
2.07
27.24
31.4
7.4
mmol/l
7.2
7.5
1.06
237
1060
(3024891) Influenza virus A+B Ag [Presence] in Specimen
441
2543
1.76
26.85
1.3
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
1876
14597
1.33
26.79
1.3
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
140
516
2.73
26.78
1.1
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
440
2540
1.76
26.69
1.8
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
3152
26318
1.26
26.04
1.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
155
611
2.55
25.95
1.6
1.3
u/ml
2.1
1.4
0.42
85
290
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
104
331
3.16
25.89
1.9
1.9
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
76
197
3.87
25.88
3.3
2.8
ml/dl
15.2
14.8
0.54
71
182
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
181
769
2.37
25.78
1.2
1.2
titre
106.7
164.8
—
9
23
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
181
769
2.37
25.78
1.3
1.2
titre
185.8
163.8
0.14
36
141
(3026250) Tacrolimus [Mass/volume] in Blood
108
357
3.04
25.23
39.8
32.9
ug/l
7.3
7.4
0.18
100
321
(3015171) Extractable nuclear Ab [Units/volume] in Serum
579
3650
1.61
25.19
1.3
1.2
u/ml
0.5
1.1
1.78
57
348
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
4529
39456
1.23
25.13
5.6
4.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
187
818
2.30
24.93
2.4
2.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
159
647
2.47
24.91
2.4
2.5
e6/l
1411.0
645.7
0.47
60
261
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
90
271
3.34
24.55
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
180
783
2.32
24.32
1.2
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
514
3181
1.64
24.10
1.5
1.4
ug/g
250.5
269.7
1.39
314
1908
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
5249
46579
1.21
23.78
2.3
2.1
pmol/l
90.7
94.7
8.63
3026
23984
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
86
257
3.36
23.75
1.1
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
1505
11552
1.34
23.35
1.4
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
470
2870
1.66
23.23
2.1
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
197
908
2.19
23.19
1.5
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
122
452
2.71
23.17
1.2
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
111
393
2.84
22.98
5.5
6.5
mmol/l
24.9
24.8
0.11
105
350
(3006245) CD3-CD19+ cells/100 cells in Blood
94
303
3.12
22.96
2.0
2.0
%
10.6
10.9
0.05
85
272
(3042111) Morphology [Interpretation] in Bone marrow Narrative
339
1897
1.81
22.90
1.8
1.5
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
36
54
6.68
22.89
1.1
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
111
395
2.82
22.76
1.9
1.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
303
1650
1.86
22.37
4.6
3.5
u/ml
50.5
37.1
0.85
293
1595
(40768804) Tissue Pathology biopsy report
4753
41959
1.21
22.27
2.4
2.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
245
1246
1.98
22.21
3.7
3.3
nmol/l
10.7
11.3
0.04
237
1216
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
424
2555
1.68
22.06
1.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
169
747
2.28
22.04
1.3
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
92
304
3.04
21.57
2.0
2.0
%
31.0
29.5
0.31
87
281
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
339
1937
1.77
21.37
4.2
3.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
276
1484
1.88
21.22
2.6
2.1
pg
32.2
32.7
0.92
270
1473
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
343
1971
1.76
21.21
1.6
1.4
pmol/l
317.4
185.8
1.40
337
1911
(3010375) cycloSPORINE [Mass/volume] in Blood
110
405
2.73
21.19
34.1
26.4
ug/l
119.1
108.7
0.93
92
335
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
278
1500
1.87
21.15
1.1
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
8803
82444
1.20
21.04
35.8
18.9
%
14.4
13.8
173.83
8664
80505
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
196
939
2.10
20.95
1.3
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
128
512
2.51
20.88
3.5
3.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
139
581
2.41
20.63
3.7
3.8
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
71
206
3.46
20.59
1.6
1.2
mg/l
277.4
32.4
1.36
51
158
(3001964) Herpes simplex virus Ag [Presence] in Specimen
84
274
3.08
20.16
1.6
1.5
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
63
172
3.67
20.01
1.3
1.2
%
117.8
107.0
0.83
56
165
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
454
2855
1.61
19.99
1.7
1.6
iu/ml
0.2
5.5
1.33
119
660
(3051651) Icteric interference index of Serum or Plasma
148
649
2.29
19.72
6.0
3.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
822
5874
1.43
19.66
3.2
3.2
pmol/l
4.3
4.4
4.20
713
5153
(3014765) Yersinia sp identified in Stool by Organism specific culture
462
2933
1.60
19.56
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
463
2942
1.59
19.53
1.3
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
114
448
2.56
19.33
4.7
4.7
mg/l
153.5
1078.2
0.70
87
308
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
289
1627
1.79
19.20
2.3
2.1
u/l
5763.8
4506.3
0.28
93
635
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
179
865
2.08
18.75
2.3
1.8
mg/l
4.3
4.3
0.08
170
816
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
57
152
3.76
18.75
1.3
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
455
2909
1.58
18.71
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
147
658
2.25
18.69
2.3
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1292
10026
1.32
18.38
2.0
1.7
%
1.6
1.5
4.28
1090
8612
(3045142) Bone marrow Pathology biopsy report
227
1203
1.90
18.32
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
2912
24897
1.22
18.18
4.6
3.8
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
112
451
2.50
18.08
1.3
1.4
%
62.6
65.5
0.37
91
368
(3044290) Cell count panel - Cerebral spinal fluid
316
1869
1.71
17.70
1.5
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
9430
98799
0.84
17.51
4.7
4.5
mmol/l
1.4
1.5
57.67
8501
89689
(3024932) HLA-DR beta [Type]
78
266
2.94
17.39
1.1
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
122
521
2.35
17.34
2.0
2.2
ml
1904.7
1921.2
0.06
115
447
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
381
2379
1.62
17.32
1.5
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
332
2002
1.67
17.31
1.3
1.2
u/ml
7.7
5.3
0.21
24
158
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
47
116
4.06
17.23
1.2
1.3
ug/l
99.4
106.4
0.10
29
76
(3007566) Smooth muscle Ab [Titer] in Serum
411
2618
1.59
17.19
1.2
1.2
titre
125.8
150.7
0.31
31
227
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
9781
102097
0.83
17.15
5.2
5.1
mmol/l
2.7
2.7
0.92
8827
92863
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
381
2393
1.61
16.91
1.3
1.3
u/ml
8.4
4.5
0.28
48
250
(3019225) pH of Specimen
1425
11335
1.29
16.79
6.6
4.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
69
224
3.09
16.77
1.7
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
78
272
2.88
16.73
4.7
4.9
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
75
256
2.94
16.71
1.1
1.2
%
99.4
104.0
0.43
69
235
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
384
2425
1.60
16.67
1.3
1.3
u/ml
4.3
6.1
1.06
75
383
(3030981) Hyaline casts [#/volume] in Urine by Automated count
814
5981
1.38
16.55
3.8
2.8
e6/l
0.4
0.3
0.98
795
5849
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
58
171
3.40
16.48
1.1
1.2
%
94.9
77.9
2.05
30
59
(3021788) Differential panel - Synovial fluid
328
1998
1.66
16.47
1.6
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
150
717
2.10
16.24
1.2
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2823
24290
1.21
16.22
1.8
1.7
pmol/l
17181810.0
28981973.3
0.78
2299
19716
(40768446) Kidney Pathology biopsy report
88
333
2.65
16.18
1.5
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
405
2611
1.57
16.11
1.3
1.3
u/ml
39.2
42.5
0.08
24
161
(3024471) HLA-A [Type]
77
273
2.83
16.04
1.0
1.0
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
64
205
3.13
15.93
2.0
2.0
e6/l
116.5
1022.6
1.42
31
109
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
9542
99654
0.84
15.89
4.7
4.6
mmol/l
4.5
4.6
2.55
8671
91074
(3001893) Eosinophils/100 leukocytes in Pleural fluid
95
377
2.53
15.87
1.3
1.5
%
1.9
2.8
0.70
82
314
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
76
270
2.82
15.78
7.5
5.4
%
72.1
69.8
0.39
66
209
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
58
177
3.29
15.63
1.3
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1112
8645
1.31
15.53
3.9
2.7
ml/min/173m2
60.3
62.8
0.92
533
3543
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
51
144
3.55
15.50
3.0
2.6
mg/l
114.3
66.2
—
5
25
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
328
2030
1.63
15.49
1.3
1.2
u/ml
8.0
17.4
—
8
24
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
72
251
2.88
15.48
1.1
1.2
%
86.7
85.6
0.08
39
128
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
385
2485
1.57
15.26
1.3
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
22
30
7.34
15.23
1.4
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
343
2172
1.59
14.77
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1961
16411
1.23
14.76
1.3
1.3
iu/ml
36.4
37.7
0.15
593
5079
(3014891) Appearance of Pleural fluid
57
180
3.18
14.56
1.6
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
198
1084
1.84
14.54
1.2
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
111
494
2.26
14.42
2.2
2.3
mmol/l
8.8
9.1
0.56
84
378
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
155
788
1.98
14.25
1.5
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
185
998
1.87
14.24
1.2
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
187
1018
1.85
14.00
1.3
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
332
2114
1.58
13.99
1.4
1.3
mmol/l
63.1
62.3
0.13
251
1697
(3039162) Centromere protein B Ab [Units/volume] in Serum
207
1165
1.79
13.90
1.3
1.3
u/ml
49.4
56.0
0.13
13
85
(4281824)
201
1122
1.80
13.88
1.2
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
122
574
2.14
13.84
2.5
2.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
353
2291
1.56
13.70
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
118
552
2.15
13.59
1.7
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
118
552
2.15
13.59
1.7
1.4
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
54
173
3.13
13.50
1.0
1.2
%
85.5
71.1
1.51
23
58
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
356
2330
1.54
13.31
1.5
1.3
mg/l
609.1
560.4
0.69
341
2196
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
150
773
1.95
13.29
1.6
1.4
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
46
135
3.41
13.24
1.3
1.4
%
66.3
75.1
1.10
41
113
(3051611) Lipemic interference index of Serum or Plasma
208
1191
1.76
13.20
5.4
3.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
64
229
2.80
13.18
2.4
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
461
6548
0.69
13.17
1.4
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
179
982
1.83
13.11
1.8
1.9
g/24h
0.4
0.9
—
8
46
(3017732) Neutrophils [#/volume] in Blood
909
7039
1.31
13.04
3.9
3.1
e9/l
4.4
4.1
2.26
675
5216
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
318
2041
1.57
12.98
1.6
1.4
e6/l
1156.0
1401.3
0.19
262
1656
(3023487) Leukocytes [#/volume] in Peritoneal fluid
90
384
2.35
12.94
1.6
2.1
e6/l
3272.1
4257.3
0.13
55
266
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
76
302
2.52
12.76
1.3
1.4
%
26.7
22.7
0.57
60
255
(3014271) Vancomycin [Susceptibility]
137
695
1.98
12.73
3.2
3.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
256
1567
1.65
12.72
3.2
2.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
397
2689
1.49
12.65
4.4
3.3
mmol/l
1.6
1.6
0.87
387
2627
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
316
2039
1.56
12.62
1.6
1.4
e6/l
12.6
30.3
1.45
252
1564
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
92
401
2.30
12.61
13.7
12.1
mmol/l
0.6
0.6
0.24
84
365
(3009214) Lutropin [Units/volume] in Serum or Plasma
306
1966
1.57
12.45
1.5
1.3
u/l
12.8
11.0
1.20
257
1597
(3014148) Varicella zoster virus Ab [Titer] in Serum
166
905
1.84
12.43
1.2
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
231
1390
1.67
12.28
5.4
4.6
umol/l
354.8
352.7
0.08
201
1167
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
110
522
2.12
12.26
1.4
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
110
522
2.12
12.26
1.4
1.5
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
81
339
2.40
12.19
1.5
1.9
e6/l
23662.2
12820.5
0.40
40
192
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
145
764
1.91
12.08
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
268
1683
1.60
12.03
1.2
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
126
636
1.99
11.91
2.6
2.1
min
507.6
498.3
0.43
86
472
(3048689) Calprotectin [Mass/mass] in Stool
1338
10988
1.24
11.89
2.4
2.1
ug/g
173.3
146.3
1.56
1074
8556
(3002256) Pathology report gross observation
1647
13826
1.22
11.86
1.4
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
291
1873
1.57
11.78
1.3
1.3
u/ml
38.2
44.2
0.28
28
200
(3044007) Cell count panel - Peritoneal fluid
74
304
2.44
11.62
1.5
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
424
2960
1.45
11.60
1.5
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
389
2673
1.47
11.57
1.7
1.6
e6/l
19149.2
14160.8
0.74
274
1910
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
103
488
2.12
11.56
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
92
417
2.21
11.54
1.5
1.8
umol/l
96.2
120.3
0.37
40
224
(21494890) Protein electrophoresis panel - 24 hour Urine
202
1195
1.70
11.48
2.4
2.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
374
2559
1.47
11.37
4.6
3.4
mmol/l
7.4
7.7
1.79
364
2504
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
211
1267
1.68
11.34
1.1
1.1
g/l
1.5
1.5
0.01
199
1130
(3044941) Cell count panel - Synovial fluid
263
1671
1.59
11.28
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
289
4356
0.66
11.27
1.5
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
66
261
2.54
11.24
1.6
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
10985
106598
1.19
11.22
35.0
18.3
mmol/l
139.4
139.6
17.19
10816
103698
(3029075) Extractable nuclear Ab panel - Serum
63
244
2.59
11.20
1.1
1.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
26
57
4.57
11.15
1.2
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
86
386
2.24
11.06
1.3
1.3
mmol/l
4.1
3.4
1.10
75
352
(3052592) Norovirus Ag [Presence] in Stool
62
241
2.58
10.95
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
1150
9373
1.25
10.92
4.7
3.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
34
93
3.66
10.91
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
113
568
2.00
10.85
1.1
1.0
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
308
2048
1.52
10.79
1.4
1.3
mmol/l
3.8
3.8
0.13
282
1916
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
113
570
1.99
10.75
1.1
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
278
1810
1.55
10.73
1.3
1.3
u/l
55.4
38.5
0.77
245
1551
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
8133
77365
1.13
10.57
4.5
4.0
pmol/l
15.0
14.9
1.32
7398
69389
(3025468) Yersinia sp identified in Specimen by Organism specific culture
221
1370
1.62
10.53
1.7
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
221
1374
1.62
10.41
1.7
1.4
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
34
97
3.51
10.28
2.2
3.5
mg/l
1.4
1.0
0.51
19
75
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
220
1371
1.61
10.27
1.7
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
319
2160
1.49
10.26
1.8
1.7
mu/l
335.5
301.4
0.89
291
1966
(3028433) Virus identified in Specimen by Culture
77
341
2.26
10.26
1.2
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
68
286
2.38
10.20
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
221
1383
1.61
10.15
1.7
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
9206
95520
0.88
10.12
4.3
4.1
mmol/l
1.4
1.3
46.25
8237
85949
(3004716) Salmonella sp identified in Stool by Organism specific culture
565
4243
1.35
10.07
1.3
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
128
689
1.87
10.07
1.9
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
224
1409
1.60
10.07
1.7
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
10990
106843
1.17
10.05
35.2
18.5
mmol/l
4.0
4.0
3.15
10817
103759
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
142
790
1.81
10.05
1.0
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
219
1371
1.61
10.04
1.7
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
194
1179
1.65
10.02
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
166
968
1.72
10.00
1.7
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
31
85
3.65
9.94
2.5
1.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
216
1353
1.61
9.89
1.7
1.5
%
56.7
60.9
0.75
131
846
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
177
1054
1.69
9.88
1.4
1.3
—
31.9
—
0
11
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
502
6699
0.74
9.83
1.8
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
174
1034
1.69
9.80
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
722
5638
1.30
9.76
1.2
1.2
iu/ml
122.3
137.7
0.47
217
2047
(3011985) Renin [Units/volume] in Plasma
217
1366
1.60
9.74
1.6
1.4
mu/l
52.2
60.5
0.34
195
1208
(3047007) Chlamydophila sp Ab [Presence] in Serum
189
1150
1.65
9.73
1.3
1.2
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
33
96
3.44
9.70
1.1
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
53
204
2.60
9.60
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
101
511
1.98
9.58
1.2
1.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
73
326
2.25
9.57
1.6
1.5
umol/l
2.1
2.0
0.31
68
307
(3038071) Oxygen [Partial pressure] in Mixed venous blood
56
224
2.51
9.38
8.3
8.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
131
729
1.80
9.30
1.5
1.4
promille
1.0
1.3
1.20
100
549
(3011648) Oxygen content in Venous blood
142
811
1.76
9.24
2.4
2.0
%
10.3
10.8
0.80
142
811
(3021162) Amylase [Enzymatic activity/volume] in Specimen
49
185
2.65
9.23
2.2
2.8
u/l
1491.3
2392.1
0.24
42
172
(3042951) Complement C1q Ab [Units/volume] in Serum
18
34
5.30
9.14
1.1
1.1
u/ml
40.5
17.7
—
5
5
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
18
34
5.30
9.14
12.4
10.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
203
1279
1.60
9.11
1.4
1.3
pmol/l
272.1
295.3
0.30
159
968
(3028707) Methadone [Presence] in Urine by Screen method
148
860
1.73
9.08
3.3
2.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
193
1208
1.61
8.92
1.2
1.1
au/ml
19.6
10.6
—
6
61
(3034274) Bile acid [Moles/volume] in Serum --fasting
118
645
1.84
8.90
1.4
1.8
umol/l
9.4
9.4
0.01
96
459
(1761868) Lipid panel - Serum or Plasma
2913
32247
0.88
8.85
3.2
3.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
97
500
1.95
8.76
1.6
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
99
514
1.93
8.76
1.1
1.1
iu/ml
7.6
3.3
—
9
28
(3002331) Protein [Mass/volume] in Peritoneal fluid
57
239
2.39
8.67
1.2
1.4
g/l
30.0
25.7
1.20
48
181
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
67
302
2.22
8.63
1.3
1.2
umol/l
3.5
3.8
0.21
61
282
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
258
1742
1.49
8.50
1.3
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
113
620
1.83
8.45
1.1
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
187
1180
1.59
8.38
1.2
1.2
u/l
62.0
63.3
0.07
140
764
(3033799) Differential panel - Peritoneal fluid
74
352
2.11
8.35
1.6
1.9
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
41
149
2.76
8.34
1.3
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1776
15466
1.17
8.33
1.3
1.2
u/ml
18.7
13.6
0.60
627
5660
(3008295) Osmolality of Serum or Plasma
178
1115
1.60
8.23
1.4
1.4
mosm/kgh2o
281.6
278.1
1.00
134
848
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
203
1313
1.55
8.19
1.4
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
103
555
1.86
8.17
1.2
1.2
u/l
214.1
377.4
1.60
95
509
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
73
349
2.10
8.14
1.2
1.3
ug/l
205.7
361.7
0.51
43
188
(3026389) Candida sp identified in Specimen by Organism specific culture
223
1475
1.52
8.13
1.4
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
54
228
2.37
8.11
1.1
1.1
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
49
198
2.48
8.09
1.6
1.6
ug/l
113.1
108.8
0.11
41
167
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
87
446
1.96
8.02
1.4
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
60
267
2.25
8.00
8.5
7.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
162
1003
1.62
7.88
1.6
1.5
%
29.8
28.6
0.16
97
612
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
218
1446
1.52
7.86
1.4
1.3
nmol/l
0.7
2.4
0.97
211
1386
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
25
70
3.58
7.82
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
56
245
2.29
7.78
1.1
1.1
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
43
167
2.58
7.72
1.2
1.3
%
20.6
23.9
0.25
34
128
(3042010) Triglyceride [Moles/volume] in Pleural fluid
43
168
2.56
7.63
1.3
1.2
mmol/l
0.7
1.5
0.89
35
111
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
55
241
2.29
7.62
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
56
248
2.26
7.57
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
58
261
2.23
7.55
1.2
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
217
1452
1.50
7.53
1.4
1.3
nmol/l
0.2
0.3
0.86
16
105
(3004775) Volume in Urine collected for unspecified duration
149
915
1.64
7.51
2.5
2.2
ml
772.2
649.8
1.45
98
611
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
43
171
2.52
7.38
1.8
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
3696
34067
1.12
7.29
3.4
3.1
mmol/l
7.4
7.3
0.41
3037
28160
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
19
46
4.13
7.25
1.5
1.6
mg/l
0.9
1.7
—
10
27
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
19
46
4.13
7.25
1.5
1.6
mg/l
2.9
1.3
0.35
13
26
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
19
46
4.13
7.25
1.5
1.6
mg/l
1.1
2.2
0.68
14
30
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
19
46
4.13
7.25
1.5
1.6
mg/l
1.2
1.6
0.21
12
21
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
19
46
4.13
7.25
1.5
1.6
mg/l
0.4
0.8
—
10
24
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
19
46
4.13
7.25
1.5
1.6
mg/l
3.2
3.5
0.08
13
26
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
19
46
4.13
7.25
1.5
1.6
mg/l
2.9
3.6
0.14
13
23
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
55
247
2.23
7.22
1.1
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
31
105
2.96
7.20
2.1
1.7
umol/l
58.4
44.1
1.06
31
105
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
60
280
2.15
7.17
3.2
3.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
192
1266
1.52
7.16
1.4
1.3
nmol/l
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
40
156
2.57
7.15
1.4
1.2
u/l
169.0
250.5
0.15
32
112
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
72
361
2.00
7.12
1.6
1.4
umol/l
31.6
29.8
0.73
72
345
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
46
194
2.38
6.98
7.3
4.9
u/l
35.3
59.1
0.88
18
67
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
45
189
2.38
6.90
1.1
1.1
pmol/l
3.1
14.3
—
5
21
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
19
48
3.96
6.87
1.5
1.6
mg/l
0.5
1.5
0.81
13
25
(4198724)
54
246
2.20
6.87
2.3
2.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
586
4667
1.27
6.87
2.6
2.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
97
544
1.79
6.84
1.8
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
114
670
1.71
6.83
1.6
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
184
1216
1.52
6.81
1.3
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
28
94
2.98
6.63
1.2
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
38
151
2.52
6.57
1.4
1.3
ng/l
161.0
635.0
0.44
25
105
(3001686) Cold agglutinin [Titer] in Serum or Plasma
46
200
2.30
6.55
1.2
1.4
titre
74.8
185.4
—
6
30
(4015189)
65
325
2.00
6.52
2.0
2.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
44
188
2.34
6.51
1.8
1.8
mmol/l
1.2
1.2
0.71
44
183
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
118
711
1.67
6.47
1.6
1.5
u/l
4.2
6.8
1.20
58
336
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
99
569
1.74
6.45
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
90
503
1.79
6.45
1.2
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
56
266
2.11
6.44
2.6
1.8
—
—
—
0
0
(3036603) Volume of Urine
117
707
1.66
6.36
1.6
1.6
ml
1825.9
1863.1
0.11
34
180
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
160
1043
1.54
6.34
1.7
1.7
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
35
136
2.58
6.34
1.3
1.3
nmol/l
8.8
289388.6
0.91
24
113
(3034891) Synovial lining cells/100 cells in Synovial fluid
90
506
1.78
6.33
1.6
1.5
%
3.0
3.6
0.22
23
111
(3023511) Choriogonadotropin [Units/volume] in Urine
127
785
1.62
6.32
1.4
1.3
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
45
197
2.29
6.32
1.4
1.5
%
11.7
10.0
0.18
30
98
(3023323) Follitropin [Units/volume] in Serum or Plasma
357
2697
1.33
6.27
1.5
1.3
iu/l
28.7
31.9
1.11
293
2324
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
54
256
2.11
6.25
1.1
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
121
741
1.64
6.25
1.5
1.3
mmol/l
2.3
2.1
0.64
113
694
(40757494) Bilirubin.total [Moles/volume] in Blood
106
629
1.69
6.18
2.7
2.2
umol/l
20.0
28.2
0.47
14
61
(3003327) Ova and parasites identified in Stool by Light microscopy
385
2954
1.31
6.07
1.7
1.7
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
78
426
1.84
6.05
1.9
1.6
nmol/l
4.9
4.8
0.01
70
356
(3051593) INR in Capillary blood by Coagulation assay
100
589
1.70
6.00
11.7
10.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
30
111
2.71
5.99
1.1
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
18
49
3.68
5.90
2.7
1.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
3555
33005
1.11
5.88
3.5
3.2
mg/l
695.9
424.4
1.93
2296
20765
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
101
601
1.69
5.85
1.8
2.0
u/field
3.0
2.6
0.19
79
412
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
144
935
1.55
5.85
1.5
1.4
u/l
27.9
31.1
0.65
132
758
(3023410) Appearance of Cerebral spinal fluid
137
883
1.56
5.76
1.7
1.5
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
33
131
2.52
5.75
4.3
3.1
umol/l
40.6
40.1
0.04
27
109
(3019150) Specific gravity of Urine by Refractometry
2510
22900
1.12
5.75
5.6
4.4
kg/l
1.0
1.0
0.05
389
3532
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
22
70
3.15
5.72
1.0
1.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
56
279
2.01
5.72
1.3
1.5
g/l
15.9
13.2
1.17
42
212
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
53
259
2.05
5.70
1.4
1.3
nmol/l
137.6
139.6
0.03
43
184
(3016244) Insulin [Units/volume] in Serum or Plasma
75
413
1.82
5.69
2.8
3.1
mu/l
36.3
24.5
0.75
66
395
(3011288) Drugs identified in Urine by Screen method
183
1257
1.46
5.69
4.2
2.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
78
435
1.80
5.68
1.2
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
17
46
3.70
5.63
5.9
4.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
706
5871
1.21
5.62
4.9
3.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
27
98
2.76
5.61
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
594
4856
1.23
5.59
1.5
1.6
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
97
579
1.68
5.58
1.8
1.5
u/l
6.2
6.2
0.01
81
481
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
80
453
1.77
5.55
2.6
2.7
—
33.0
—
0
6
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
32
128
2.50
5.51
1.1
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
75
418
1.80
5.49
2.2
2.5
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
20
62
3.23
5.43
2.4
3.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
46
218
2.11
5.38
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
45
213
2.12
5.29
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
257
1900
1.36
5.28
2.5
2.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
32
131
2.45
5.26
1.2
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
123
791
1.56
5.26
1.2
1.2
u/ml
97.0
67.6
—
9
35
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
106
658
1.62
5.26
1.3
1.2
u/l
35.5
25.3
0.80
96
537
(3027008) Opiates [Presence] in Urine
258
1912
1.36
5.22
2.5
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
301
2283
1.33
5.22
1.7
1.7
iu/l
4.0
4.6
0.64
96
757
(3044927) Protein electrophoresis panel - Urine
176
1222
1.45
5.21
1.2
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
103
637
1.62
5.19
1.2
1.2
mg/l
48.4
41.2
0.55
89
530
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
89
530
1.68
5.19
2.8
2.6
u/l
236.1
204.5
1.59
89
525
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
108
676
1.60
5.19
1.3
1.2
u/l
99.2
92.3
0.31
98
571
(3034988) Calcium [Moles/volume] in Capillary blood
43
202
2.13
5.16
1.8
1.8
mmol/l
1.2
1.2
0.45
43
195
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
123
795
1.55
5.15
1.2
1.2
u/ml
34.4
35.1
0.02
12
63
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
19
59
3.22
5.15
2.1
2.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
258
1918
1.35
5.13
2.5
2.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
136
900
1.52
5.12
1.6
1.6
u/ml
28.9
24.8
0.38
37
187
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
31
127
2.44
5.10
1.4
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
220
1597
1.38
5.08
1.2
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
15
40
3.75
5.08
1.1
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
102
634
1.61
5.05
1.7
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
3717
34792
1.09
5.05
4.3
3.9
mg/mmol
11.6
9.4
1.84
2338
21791
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
117
752
1.56
5.04
1.2
1.2
u/ml
2.2
5.4
—
5
42
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
31
128
2.42
5.02
2.3
2.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2212
20196
1.11
4.95
1.3
1.2
u/ml
1.4
1.8
1.58
571
5233
(3041918) Cholesterol [Moles/volume] in Pleural fluid
46
226
2.04
4.93
1.3
1.2
mmol/l
2.1
1.5
2.27
33
142
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
77
448
1.72
4.91
1.6
1.3
%
44.8
63.2
0.87
11
58
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
27
106
2.55
4.86
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
141
952
1.49
4.85
1.1
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
115
744
1.55
4.83
1.3
1.3
titre
65.7
61.0
—
7
63
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
83
497
1.67
4.78
1.0
1.1
iu/ml
6.1
11.1
1.93
23
116
(3045414) Leukocytes [Presence] in Urine
573
4753
1.21
4.73
2.2
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
406
3246
1.26
4.73
5.8
4.4
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
13
33
3.94
4.70
1.1
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
123
814
1.52
4.67
1.3
1.2
u/ml
54.0
51.6
—
5
40
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
9734
99494
0.91
4.65
5.2
4.8
mmol/l
6.1
6.0
8.35
8795
89471
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
97
609
1.60
4.65
1.1
1.1
mg/l
361.3
280.5
0.73
87
529
(3016273) Islet cell 512 Ab [Units/volume] in Serum
14
38
3.69
4.63
1.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
12
29
4.14
4.62
1.2
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
27
109
2.48
4.61
1.1
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
69
2.90
4.59
1.1
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
117
770
1.52
4.57
1.2
1.1
mmol/l
32.6
35.3
0.58
101
635
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
31
134
2.32
4.57
2.2
2.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
117
771
1.52
4.55
1.3
1.3
titre
692.5
349.2
0.36
12
63
(3035320) C reactive protein [Mass/volume] in Body fluid
115
755
1.53
4.54
3.0
2.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
236
1768
1.34
4.51
2.6
2.0
—
—
—
0
0
(3024316) Viscosity of Plasma
15
44
3.41
4.45
2.2
1.4
mpas
1.8
1.6
—
8
28
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
12
30
4.00
4.43
1.1
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
9813
95925
1.09
4.34
27.9
14.8
ml/min/173m2
75.5
76.5
4.63
8676
79381
(40768443) Skin Pathology biopsy report
577
4834
1.20
4.33
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
202
1488
1.36
4.33
2.6
2.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
45
232
1.94
4.27
3.4
2.3
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
7
6
11.67
4.27
1.6
3.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
55
303
1.82
4.27
1.2
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
73
437
1.67
4.25
2.7
2.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
82
507
1.62
4.22
1.2
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
22
84
2.62
4.21
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
246
1875
1.32
4.20
2.5
1.9
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
10
23
4.35
4.08
2.6
3.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
61
352
1.74
4.07
1.0
1.1
miu/ml
1563.4
1496.2
0.18
61
352
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
89
567
1.57
4.06
1.2
1.1
u/l
38.0
27.6
0.75
70
418
(3010838) Calcium [Moles/time] in 24 hour Urine
84
529
1.59
4.03
1.5
1.6
mmol/24h
4.2
5.9
—
6
41
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
146
1032
1.42
4.03
1.2
1.1
iu/ml
2.5
1.9
—
6
28
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
89
569
1.57
4.01
1.2
1.1
u/l
99.4
89.7
0.45
73
435
(3013293) Extractable nuclear Ab [Presence] in Serum
32
149
2.15
4.00
1.4
1.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
47
252
1.87
4.00
1.5
1.6
ug/l
0.3
0.4
1.69
34
153
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
11
28
3.93
3.97
1.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
41
211
1.95
3.94
1.6
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
76
470
1.62
3.94
1.2
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
37
184
2.01
3.91
2.1
2.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
39
199
1.96
3.85
1.1
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
339
2726
1.25
3.83
3.3
3.1
nmol/l
0.8
0.8
0.44
243
2096
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
194
1453
1.34
3.79
2.4
2.1
mg/l
31.6
25.5
0.58
57
369
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
121
2.23
3.72
2.9
5.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
29
134
2.17
3.71
1.4
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
29
134
2.17
3.71
1.4
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
29
134
2.17
3.71
1.4
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
36
181
1.99
3.71
6.6
7.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
818
7161
1.15
3.64
2.4
2.1
nmol/l
10.5
12.4
9.72
700
6265
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
20
79
2.53
3.62
1.4
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
40
3.25
3.61
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
9231
90243
1.08
3.58
31.4
16.9
%
38.4
39.2
10.58
6015
60222
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
18
68
2.65
3.55
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
113
782
1.45
3.54
1.2
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
27
124
2.18
3.52
1.4
1.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
14
46
3.04
3.52
1.1
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
431
3590
1.21
3.51
1.7
1.6
—
—
—
0
0
(44813793)
88
584
1.51
3.41
1.1
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
16
58
2.76
3.41
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
289
3578
0.80
3.37
1.6
1.7
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
10
27
3.70
3.35
1.1
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
10
27
3.70
3.35
1.1
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
10
27
3.70
3.35
1.1
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
10
27
3.70
3.35
1.1
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
10
27
3.70
3.35
1.1
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
37
3.24
3.33
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
39
210
1.86
3.33
1.0
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
16
59
2.71
3.31
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
140
1021
1.37
3.29
1.1
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
15
54
2.78
3.24
1.3
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
136
991
1.38
3.23
2.3
2.2
u/field
2.2
2.0
0.14
66
368
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
247
1958
1.27
3.22
1.8
1.6
nmol/l
1.0
0.8
3.34
208
1636
(3003888) Timothy IgE Ab [Units/volume] in Serum
152
1129
1.35
3.20
1.0
1.1
u/ml
3.6
4.2
0.22
80
535
(3013862) HLA-DP [Type]
10
28
3.57
3.19
1.1
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
20
85
2.35
3.14
1.1
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
203
1577
1.29
3.12
1.4
1.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
16
61
2.62
3.12
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1143
12619
0.90
3.12
1.4
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
190
1468
1.30
3.06
1.3
1.3
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
10
29
3.45
3.04
1.3
1.4
nmol/l
414.9
543.2
—
10
29
(21494567) Legionella sp IgM Ab [Presence] in Serum
16
62
2.58
3.03
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
333
2754
1.21
2.98
2.7
2.3
ug/min
143.7
103.8
0.61
204
1622
(3028468) Fragments [Presence] in Blood by Light microscopy
5
5
10.00
2.98
4.0
1.0
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
5
5
10.00
2.98
1.4
1.4
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
5
10.00
2.98
2.6
1.8
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
23
107
2.15
2.95
1.2
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
27
134
2.02
2.94
1.5
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
9510
93301
1.07
2.92
5.4
4.8
mu/l
2.2
2.1
0.07
8711
84211
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
60
380
1.58
2.92
1.2
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
167
1278
1.31
2.90
1.1
1.1
u/ml
0.8
1.3
0.81
70
483
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
68
444
1.53
2.90
1.2
1.1
u/l
1.1
1.1
0.21
36
203
(3008401) Mugwort IgE Ab [Units/volume] in Serum
145
1088
1.34
2.89
1.0
1.1
u/ml
0.9
1.0
0.14
63
429
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
27
135
2.00
2.89
1.1
1.1
u/l
18.3
18.4
0.02
21
89
(40761511) CBC panel - Blood by Automated count
10661
105035
1.08
2.86
27.8
14.9
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
15
58
2.59
2.86
2.8
1.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
29
150
1.93
2.83
1.2
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2541
26930
0.93
2.78
1.7
1.6
mmol/l
1.5
1.4
17.71
2092
22304
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
696
6149
1.14
2.78
2.6
2.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
84
579
1.45
2.78
1.7
1.7
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
6
10
6.00
2.69
1.2
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
34
191
1.78
2.61
1.4
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
220
1770
1.25
2.60
1.7
1.5
—
—
—
0
0
(4027681)
69
465
1.49
2.58
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
804
7208
1.12
2.56
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
40
238
1.68
2.52
1.1
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
9374
95279
0.94
2.46
6.8
6.2
mmol/mol
41.1
40.4
10.57
8601
87050
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
81
570
1.42
2.44
1.1
1.1
nmol/l
5.9
9.1
0.30
17
124
(3022621) pH of Urine by Test strip
802
7213
1.12
2.43
3.9
3.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
11075
111951
0.93
2.43
44.1
23.1
g/l
129.7
134.1
154.69
10941
109942
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
29
159
1.83
2.42
12.2
10.7
mmol/l
5.5
5.4
0.10
29
159
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
31
174
1.78
2.40
1.4
1.2
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
6
12
5.00
2.40
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
60
400
1.50
2.39
1.2
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
11075
111935
0.93
2.38
43.7
22.9
e12/l
4.3
4.4
70.34
10807
108199
(3014051) Protein [Presence] in Urine by Test strip
294
2463
1.20
2.37
2.6
2.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
42
258
1.63
2.37
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
42
258
1.63
2.37
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
42
258
1.63
2.37
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
42
258
1.63
2.37
1.1
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
47
297
1.58
2.37
1.2
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
17
77
2.21
2.36
1.2
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
20
97
2.06
2.36
1.9
2.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
11075
111927
0.93
2.35
43.6
22.9
fl
91.6
91.4
4.56
10932
109909
(3033923) Metanephrine [Moles/time] in 24 hour Urine
38
228
1.67
2.35
1.3
1.1
umol/24h
0.6
0.7
0.03
17
105
(3039443) Prostate specific Ag panel - Serum or Plasma
138
1774
0.78
2.34
1.6
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
11075
111919
0.93
2.32
43.5
22.8
pg
30.2
30.4
18.54
10932
109899
(3010813) Leukocytes [#/volume] in Blood
11079
111956
0.93
2.32
43.8
23.0
e9/l
7.2
6.8
35.33
10819
108215
(3036071) Salmonella sp Ab [Titer] in Serum
43
268
1.61
2.30
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
130
998
1.31
2.29
1.1
1.1
u/ml
1.4
1.8
0.24
31
229
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
56
372
1.51
2.28
3.9
2.9
umol/l
28.6
28.4
0.06
43
277
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
61
413
1.48
2.27
1.9
2.2
umol/l
56.9
55.7
0.11
43
333
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
13
53
2.45
2.27
1.2
1.1
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
36
217
1.66
2.20
1.4
1.3
mu/l
148.7
61.7
0.82
29
154
(3048879) Bone marrow aspiration report
53
351
1.51
2.20
1.7
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
11075
111880
0.93
2.20
43.8
22.9
e9/l
251.7
245.9
13.89
10839
108533
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
67
466
1.44
2.19
1.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
12
48
2.50
2.18
2.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
52
344
1.51
2.17
1.3
1.5
pmol/l
14.5
16.3
1.51
39
286
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
192
1559
1.23
2.16
1.7
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
287
2424
1.19
2.15
5.0
3.6
mg/l
28.9
28.9
0.01
207
1549
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
50
329
1.52
2.15
1.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
26
144
1.81
2.13
2.5
2.7
u/field
0.8
0.5
0.60
26
144
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
114
870
1.31
2.12
1.5
1.4
nmol/l
0.3
0.3
0.08
81
646
(3001186) Copper [Moles/volume] in Serum or Plasma
35
212
1.65
2.12
1.5
1.2
umol/l
16.6
16.9
0.11
30
192
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
23
123
1.87
2.10
1.7
2.0
umol/l
17.8
18.4
0.08
23
123
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
132
1679
0.78
2.09
1.6
1.5
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
5
10
5.00
2.07
1.2
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
56
382
1.47
2.04
1.1
1.1
ng/l
263.6
541.9
0.65
17
95
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
15
4.00
2.03
2.7
1.6
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
6
15
4.00
2.03
2.0
8.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
15
4.00
2.03
2.7
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
47
310
1.52
2.01
2.1
1.8
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
10
38
2.63
2.00
1.3
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
95
714
1.33
1.99
1.2
1.3
mmol/l
11.5
12.0
0.22
44
205
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
44
287
1.53
1.99
1.3
1.2
%
114.6
112.1
0.24
37
249
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
23
126
1.83
1.97
1.3
1.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
35
217
1.61
1.96
1.2
1.2
—
429.1
—
0
11
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
17
84
2.02
1.95
1.0
1.1
u/l
7.4
12.9
0.88
17
84
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
713
6462
1.11
1.94
2.4
2.4
au/ml
23.3
25.9
0.20
27
291
(3020961) Endomysium IgA Ab [Titer] in Serum
464
4102
1.14
1.94
1.1
1.1
titre
126.9
207.5
0.63
11
102
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
3921
37819
1.05
1.93
5.0
5.1
ug/l
3.6
3.6
0.04
3422
33716
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
20
106
1.89
1.90
1.1
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
46
308
1.49
1.86
1.3
1.2
g/l
0.3
0.3
0.72
37
242
(3041672) Baker's yeast Ab [Presence] in Serum
9
34
2.65
1.86
1.1
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
101
775
1.31
1.85
1.2
1.2
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
12
53
2.26
1.80
3.2
10.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
114
893
1.28
1.80
1.3
1.3
nmol/l
1.7
1.4
1.71
103
803
(3008116) Ketones [Moles/volume] in Urine by Test strip
35
223
1.57
1.78
1.2
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
40
263
1.52
1.77
1.1
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
75
556
1.35
1.76
1.4
1.3
nmol/l
1.3
1.2
0.47
54
429
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
569
5133
1.11
1.72
1.8
1.8
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
8
30
2.67
1.72
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
646
5871
1.11
1.70
1.3
1.3
au/ml
43.9
52.2
0.41
22
253
(3010144) Erythrocytes [#/volume] in Synovial fluid
132
1061
1.25
1.70
1.5
1.3
e6/l
183467.8
152608.2
0.16
91
710
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
21
118
1.78
1.69
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
70
936
0.75
1.68
1.4
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
20
111
1.80
1.68
1.6
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
554
6112
0.90
1.62
1.3
1.3
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
5
14
3.57
1.61
1.6
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
19
106
1.79
1.58
1.6
2.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
40
576
0.69
1.53
1.5
1.5
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
14
71
1.97
1.53
1.1
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
225
1927
1.17
1.53
1.3
1.3
miu/ml
271.3
216.3
1.00
68
806
(3001556) Androgen free Index in Serum or Plasma
10
44
2.27
1.53
2.9
1.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
5
15
3.33
1.52
1.8
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
628
5745
1.10
1.49
1.8
1.9
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
13
65
2.00
1.48
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
99
785
1.26
1.47
2.1
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
17
94
1.81
1.46
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
18
102
1.77
1.44
1.0
1.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
16
3.12
1.43
1.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
12
59
2.03
1.43
1.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
12
59
2.03
1.43
1.2
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
12
59
2.03
1.43
1.5
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
76
587
1.30
1.40
1.4
1.2
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
44
312
1.41
1.40
1.4
1.3
%
40.5
23.7
0.63
11
47
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
75
579
1.30
1.39
1.4
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
99
793
1.25
1.37
1.1
1.1
u/ml
5.9
3.1
0.41
39
303
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
181
2119
0.85
1.36
1.4
1.5
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
5
17
2.94
1.36
1.8
1.1
umol/l
1408.0
2536.5
—
5
17
(3020491) Glucose [Moles/volume] in Blood
94
751
1.25
1.34
2.2
2.0
mmol/l
7.3
7.0
0.62
77
510
(3035933) Granulocytes/100 leukocytes in Blood
31
207
1.50
1.34
2.1
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
35
240
1.46
1.33
1.1
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
162
1371
1.18
1.31
1.1
1.1
iu/ml
47.3
8209.8
0.56
36
295
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1405
13329
1.06
1.29
1.5
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
18
106
1.70
1.29
1.5
1.1
umol/24h
1.8
1.7
0.15
18
106
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
25
161
1.55
1.28
2.1
1.5
au/ml
240.3
98.6
—
6
16
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
17
99
1.72
1.26
1.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
50
370
1.35
1.26
1.2
1.2
g/l
37.2
39.8
0.41
22
188
(3019420) Tryptase [Mass/volume] in Serum or Plasma
60
458
1.31
1.24
1.5
1.6
ug/l
8.7
8.8
0.04
54
407
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
68
868
0.78
1.24
1.4
1.4
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
20
123
1.63
1.23
1.3
1.3
—
91.2
—
0
6
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
32
220
1.46
1.22
1.4
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
68
866
0.78
1.22
1.4
1.4
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
37
262
1.41
1.22
2.4
2.4
mmol/l
6.8
7.8
1.22
21
162
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
11
56
1.96
1.21
1.2
1.1
u/l
3.2
4.4
—
6
12
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
32
221
1.45
1.20
2.4
3.0
mg/l
8.0
7.3
0.16
19
179
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
63
488
1.29
1.18
1.5
1.5
ug/l
2.6
4.9
1.24
40
394
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
66
515
1.28
1.17
1.5
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
57
738
0.77
1.17
1.4
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
55
715
0.77
1.17
1.3
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
22
141
1.56
1.16
1.6
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1275
13407
0.95
1.15
4.6
4.7
%
31.1
32.9
7.02
893
8853
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
69
869
0.79
1.14
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
69
868
0.79
1.13
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
61
777
0.78
1.12
1.4
1.5
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
7
31
2.26
1.10
1.3
1.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
408
3723
1.10
1.09
1.1
1.1
u/ml
1.7
11.3
0.78
11
59
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
10893
108091
1.04
1.09
18.2
10.7
u/l
26.8
25.8
3.44
10633
103584
(3047352) Trisomy 18 risk [Likelihood] in Fetus
56
718
0.78
1.09
1.4
1.4
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
7
32
2.19
1.08
2.6
1.2
—
—
—
0
0
(4024509)
131
1113
1.18
1.07
1.7
1.6
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
86
702
1.23
1.07
1.1
1.0
mg/l
313.8
285.7
2.59
80
628
(3018834) Bilirubin.total [Presence] in Urine by Test strip
10
52
1.92
1.06
1.8
3.4
—
0.0
—
0
9
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
22
2.27
1.03
1.4
2.0
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
29
204
1.42
1.02
2.2
2.4
au/ml
256.5
134.7
—
6
33
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
23
155
1.48
1.00
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
365
3331
1.10
1.00
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
87
1048
0.83
0.99
1.5
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
57
449
1.27
0.98
1.0
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
33
240
1.38
0.98
1.2
1.2
pmol/l
476.2
268.4
1.06
22
174
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
56
706
0.79
0.97
1.9
1.7
—
—
—
0
0
(4146454)
105
1240
0.85
0.96
2.6
2.6
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
10
54
1.85
0.96
1.2
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
10
54
1.85
0.96
1.9
1.4
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.0
—
0.1
—
0
17
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.0
—
0.5
—
0
23
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
35
258
1.36
0.96
1.2
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
245
2727
0.90
0.96
1.8
1.8
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
33
241
1.37
0.96
1.4
1.4
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
90
749
1.20
0.95
2.0
2.0
ug/l
2.4
2.4
0.07
69
624
(3003338) MCHC [Mass/volume]
8279
83684
0.97
0.95
38.3
20.3
g/l
329.2
331.8
111.46
8193
82869
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
11
62
1.77
0.94
1.1
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
15
93
1.61
0.93
1.5
1.9
mmol/l
0.7
1.1
—
9
59
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
85
706
1.20
0.92
1.0
1.0
u/ml
0.1
0.3
2.21
22
156
(3022475) Manganese [Moles/volume] in Blood
10
55
1.82
0.92
1.2
1.4
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
16
102
1.57
0.90
1.8
2.0
%
76.3
62.8
—
9
65
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
99
837
1.18
0.90
4.3
5.1
u/ml
30.2
83.1
1.77
23
248
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
44
340
1.29
0.90
1.2
1.2
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
60
740
0.81
0.88
1.0
1.0
ng/l
32.2
44.1
3.19
40
500
(3028717) Thiamine [Mass/volume] in Blood
16
103
1.55
0.87
1.3
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
60
737
0.81
0.86
1.1
1.0
ng/l
733.4
708.1
0.18
38
490
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
60
735
0.82
0.84
1.0
1.0
ng/l
255.5
330.2
2.32
41
507
(3034092) Cytoplasmic Ig cells/100 cells in Blood
19
129
1.47
0.83
17.1
11.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
22
154
1.43
0.83
1.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
114
0.53
0.82
1.0
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
6
32
1.87
0.81
1.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
14
89
1.57
0.81
1.2
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
49
391
1.25
0.80
1.1
1.1
u/ml
5.3
4.1
0.19
13
60
(3014133) Dog dander IgE Ab [Units/volume] in Serum
101
868
1.16
0.78
1.1
1.1
u/ml
2.9
3.0
0.04
42
321
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
14
90
1.56
0.78
1.1
1.2
nmol/l
0.2
0.3
—
7
59
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
14
90
1.56
0.78
1.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
18
123
1.46
0.77
1.6
1.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
13
83
1.57
0.74
3.2
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
236
2587
0.91
0.74
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
2100
21562
0.97
0.69
3.1
3.1
ug/l
0.8
0.8
0.27
1469
14841
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
5
27
1.85
0.68
1.4
1.1
%
1.0
2.8
—
5
27
(3010015) Selenium [Moles/volume] in Serum or Plasma
10
61
1.64
0.68
2.3
2.0
umol/l
1.3
1.4
—
10
56
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
28
213
1.31
0.68
2.7
1.7
ug/l
3.7
2.2
0.81
17
112
(3026470) Cobalt [Mass/volume] in Blood
89
769
1.16
0.67
2.0
1.9
ug/l
4.0
3.7
0.11
76
676
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
72
613
1.18
0.66
5.4
6.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
12
78
1.54
0.65
1.0
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
21
154
1.36
0.64
1.2
1.3
%
63.1
52.4
0.51
12
66
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
54
644
0.84
0.63
1.5
1.3
pmol/l
65.8
113.0
0.49
28
203
(3022689) Creatine [Moles/volume] in Urine
24
313
0.77
0.61
1.7
1.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
20
147
1.36
0.61
1.1
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
28
217
1.29
0.61
2.5
2.1
ug/l
3.6
3.7
—
7
82
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
105
1182
0.89
0.58
1.2
1.2
mmol/l
8.6
7.6
1.73
71
863
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2962
30178
0.98
0.58
4.3
4.4
%
21.6
22.1
1.10
1457
15261
(3010937) Rubella virus Ab [Presence] in Serum
6
35
1.71
0.57
1.2
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
21
275
0.76
0.56
2.1
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
272
2918
0.93
0.56
2.0
1.6
mg/l
5.5
3.7
1.39
220
2091
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
34
274
1.24
0.56
1.6
1.3
%
41.8
33.7
0.61
24
177
(40768793) Breast Pathology biopsy report
235
2177
1.08
0.55
1.3
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
10
65
1.54
0.55
1.5
2.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
34
275
1.24
0.55
3.9
1.6
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
13
92
1.41
0.50
1.2
1.2
%
26.7
19.6
—
6
24
(3045683) HLA typing for celiac disease panel - Blood or Tissue
38
455
0.83
0.49
1.0
1.0
—
—
—
0
0
(4211845)
68
594
1.15
0.49
3.4
3.6
—
—
—
0
0
(3001729) Color of Synovial fluid
14
101
1.39
0.49
1.5
1.5
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
191
1767
1.08
0.49
2.1
1.9
pmol/l
180.0
197.8
1.51
183
1645
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
7
45
1.56
0.48
1.3
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
20
154
1.30
0.48
1.9
3.3
ng/l
39.4
162.6
—
8
52
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
7
47
1.49
0.47
2.3
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
16
211
0.76
0.47
1.4
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
120
1091
1.10
0.46
1.2
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
28
227
1.23
0.46
2.0
1.5
ng/l
108.2
123.9
0.41
28
227
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
14
103
1.36
0.45
1.3
1.0
iu/ml
10.6
15.6
—
5
44
(3025549) Creatine [Moles/time] in 24 hour Urine
12
87
1.38
0.42
1.2
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
62
547
1.13
0.41
3.5
3.7
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
15
114
1.32
0.40
2.8
2.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
65
577
1.13
0.40
2.3
2.1
ug/min
24.6
152.5
2.09
11
133
(3003740) Influenza virus B Ag [Presence] in Specimen
119
1093
1.09
0.39
1.2
1.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
10
71
1.41
0.39
1.0
5.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
18
225
0.80
0.37
5.8
6.4
—
—
—
0
0
(4133840)
20
246
0.81
0.37
1.6
1.2
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
1.0
1.1
nmol/l
224.8
257.4
—
6
43
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
9
126
0.71
0.35
1.1
1.1
u/ml
95.4
58.5
—
9
120
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
44
1.36
0.34
1.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
303
2893
1.05
0.34
1.9
1.8
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
11
83
1.33
0.32
1.5
1.8
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
7
52
1.35
0.31
1.9
3.5
g/mol
55.0
45.1
—
7
46
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
26
221
1.18
0.30
2.2
2.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
33
378
0.87
0.30
1.5
1.4
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
11
84
1.31
0.30
2.1
1.9
%
8.6
16.7
—
5
47
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
56
1.25
0.29
3.6
3.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
248
2372
1.05
0.28
1.1
1.1
u/ml
3.6
7.9
1.73
19
232
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
460
4455
1.03
0.28
1.1
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
10
76
1.32
0.28
1.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
64
585
1.09
0.27
1.2
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
8
66
1.21
0.26
2.5
1.5
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
33
292
1.13
0.24
1.4
1.5
mmol/l
8.9
8.3
0.35
17
166
(44806420)
40
359
1.11
0.24
1.9
2.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
36
402
0.89
0.24
1.4
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
110
1037
1.06
0.23
3.1
3.0
mg/l
84.4
44.4
0.70
81
759
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
16
135
1.18
0.21
1.2
1.2
mmol/l
4.0
6.5
—
8
63
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1424
14051
1.01
0.20
11.6
7.7
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
40
364
1.10
0.20
1.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
25
222
1.13
0.19
1.4
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
33
363
0.91
0.18
1.2
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
7
58
1.21
0.18
2.1
1.4
umol/24h
326.4
323.9
—
7
58
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
10
82
1.22
0.17
1.2
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
69
1.16
0.16
1.3
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
71
751
0.94
0.16
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
679
6680
1.02
0.16
1.2
1.2
—
—
—
0
0
(4094501)
282
2749
1.03
0.15
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
265
2582
1.03
0.15
1.1
1.1
—
—
—
0
0
(4034850)
354
3472
1.02
0.12
18.3
10.7
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
15
169
0.89
0.12
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
34
316
1.08
0.12
1.1
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
14
124
1.13
0.11
1.9
3.4
mmol/l
7.5
7.9
—
7
60
(40758358) Immune stain study
5
45
1.11
0.09
1.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
12
106
1.13
0.09
1.0
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
35
371
0.94
0.09
1.1
1.0
u/ml
0.5
0.7
—
9
82
(3006270) Folate [Moles/volume] in Blood
105
1019
1.03
0.09
1.3
1.2
nmol/l
335.7
340.3
0.05
79
816
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
19
174
1.09
0.09
1.1
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
14
126
1.11
0.09
1.4
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1023
10155
1.01
0.08
1.6
1.6
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
7
85
0.82
0.07
1.1
1.0
u/ml
0.0
1.2
—
7
58
(3025315) Body weight
9
88
1.02
0.07
4.7
4.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
26
273
0.95
0.05
1.4
1.6
ug/l
11.0
9.0
0.68
26
273
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
17
181
0.94
0.05
1.1
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
237
2386
0.99
0.03
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
232
2303
1.01
0.02
2.0
1.8
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
10
93
1.07
0.02
6.2
6.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
10
93
1.07
0.02
3.1
3.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
72
729
0.99
0.01
1.6
1.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
19
183
1.04
0.01
1.2
1.1
u/ml
0.7
1.3
—
9
88
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
25
256
0.98
0.00
1.2
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
110
1106
0.99
0.00
1.1
1.1
u/ml
6.6
3.3
0.52
38
442
(4212803)
12
122
0.98
0.00
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
36
355
1.01
0.00
1.4
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
10
104
0.96
0.00
12.8
4.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
94
940
1.00
0.00
1.5
1.7
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
38
382
0.99
0.00
1.1
1.0
u/ml
0.5
2.2
—
10
110
(40765089) Chromosome analysis panel - Blood by G-banded
12
119
1.01
0.00
1.0
1.0
—
—
—
0
0
(3035153) Lemon IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025504) Homovanillate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002853) Influenza virus B Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
54
0.93
0.00
5.6
8.3
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
76
0.92
0.00
1.3
1.1
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
31.0
—
0
6
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
51
0.98
0.00
1.8
1.1
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
5
55
0.91
0.00
1.0
1.2
—
1.2
—
0
9
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
6
0.00
0.00
0.0
5.2
—
11.7
—
0
6
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
70
1.00
0.00
1.1
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
5
53
0.94
0.00
1.4
1.2
—
0.1
—
0
13
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: FG_PULMHEART – Pulmonary heart disease
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).